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A R T I C L E
Demobilised troops and approved schools: 
Th e aftermath of the First World War 




Th e impact of the First World War on a wide range of 
professions has been well documented. Th e upheaval of 
the workforce and the return of demobilised men led 
to an unprecedented and seismic reconsideration of en-
try requirements, educational needs, capacity and pri-
orities at a national level. Th is article explores the situ-
ation for pharmacy, and particularly the national 
post-war educational context, through local case stud-
ies of new schools of pharmacy in Cardiff , Swansea and 
Portsmouth. In Cardiff  and Portsmouth pharmacy ed-
ucation centenaries have been celebrated in 2019, whilst 
Swansea University will launch a new pharmacy degree 
programme in 2020, some 101 years after an earlier in-
carnation was established.
Introduction
Th e economic structure upon which our work, our 
habits, our customs as a people were based was shat-
tered, and a new order had to be rapidly impro-
vised.1
Sir William Glyn-Jones
Secretary and Registrar of the Pharmaceutical 
Society of Great Britain
At the end of the First World War, the impact of the 
signifi cant numbers of returning servicemen acted as a 
national economic catalyst to technical and vocational 
education. By January 1920, when conscription in Brit-
ain ended, approximately 4 million men had been de-
mobilised, with around 400,000 having no work to re-
turn to.2 In 1919 around 4,000 ex-servicemen applied 
to the Central Grants Committee for state-aided phar-
maceutical training. At that time the capacity of exist-
ing schools of pharmacy in Great Britain was about 500 
students, and so this demand prompted the Ministry 
of Labour to ask the Pharmaceutical Society of Great 
Britain (PSGB) to arrange for and to approve addition-
al schools to train them.3
An article in Th e Chemist and Druggist on 12 April 
1919 outlined the scheme for ‘Training Demobilised 
Men’. It explained that the government were going to 
consider the men returning from service in three sepa-
rate classes: 1) those who had suffi  cient experience, but 
needed to pass the Qualifying examination of the 
PSGB; 2) those who still needed to complete an al-
ready-started apprenticeship or gain additional practi-
cal experience; and 3) those who had no previous expe-
rience or qualifi cation ‘but who are properly advised to 
take up the calling’. Demobilised men were strongly 
advised to take up the full nine month course leading 
to the Qualifying examination, the piece describing the 
option of taking a shorter or intensive course as ‘a false 
economy of his own time and of the government mon-
ey’ if he failed the examination for lack of study.4
However, the importance of colleges off ering part-
time options was stressed: some men who had achieved 
suffi  cient experience before they enlisted would be best 
placed to go back to work and study part-time for qual-
ifi cation, and those who needed to undertake practical 
experience could attend courses during their appren-
ticeship.5 Th e emphasis was on achieving the required 
standards and not cutting corners, but also on getting 
men back into work as quickly and effi  ciently as possi-
ble. Following negotiations between the government 
and William Glyn-Jones representing the profession, 
demobilised pharmacy students were entitled to the 
Government Training Grant, covering college fees, ex-
amination fees and maintenance costs for the full nine 
month course, at a total cost to taxpayers of about 
£400,000. Th e Society organised the selection process, 
allocating successful candidates to suitable courses.6
A condition of the Government grants allocated to 
ex-servicemen was that they had to attend a course at 
an ‘approved’ institution. However, for pharmacy, this 
was not something already in place. Th e PSGB Council 
saw an opportunity to put into operation the powers 
given to them by the Poisons and Pharmacy Act of 1908 
to require attendance at a course of instruction as a con-
dition of entry for their Qualifying examination, and 
therefore to codify the educational standard with cours-
es derived from a compulsory national curriculum. Er-
nest Saville Peck was given the role of visiting universi-
ties and technical colleges to ‘approve’ them as having 
facilities and staffi  ng suffi  cient to take on this infl ux of 
new students. In just three months, he arranged cours-
es covering both Part I and Part II of the Qualifying 
examination in 25 institutions, and an even larger 
number to teach Part I only.7
Th e courses
Th e Qualifying examination was newly-established in 
1918, re-worked from the PSGB’s existing Minor ex-
amination. By 1920 it was split into two Parts: Part I 
consisted of pure science (chemistry, physics and bota-
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ny); Part II was an applied pharmaceutical section (ma-
teria medica, pharmacy including posology (study of 
dosages), the translation and dispensing of prescrip-
tions, and poisons laws). Th e two Parts of the examina-
tion could be taken together or separately.
To accommodate the post-war boom in students, 
an unlimited number of schools were allowed to teach 
Part I in order to facilitate these numbers and to allow 
students to study close to home, but the number al-
lowed to teach Part II was restricted to allow a level of 
control over the purely pharmaceutical elements, and 
so that – once the boom in demobilised students had 
passed – there was not a surplus of pharmacy school 
places. As a piece in Th e Chemist and Druggist stressed, 
the demand was ‘a temporary one owing to the large 
number of ex-Service men who are taking the Qualify-
ing examination before returning to the pharmacy or 
dispensary’.8
Th e new, applied pharmaceutical section in Part II, 
including dispensing of prescriptions and supply of 
scheduled poisons, was particularly prompted by the 
need to produce pharmacists to fulfi l the duties of the 
1911 National Insurance (N.I.) Act, whose impact was 
only fully felt after the First World War. Its implemen-
tation in July 1912 meant that free medical treatment 
was supplied to all insured people. Th is had a signifi -
cant impact for retail pharmacists who were part of the 
‘panels’ that were authorised to provide N.I. prescrip-
tions. Before 1913, 90 per cent of dispensing took place 
in doctors’ surgeries, and one provincial pharmacy re-
ported dispensing only 43 prescriptions in nine years. 
Now, pharmacists were a key part of a system that 
marked the fi rst step towards today’s welfare state in 
Britain.9
A Regulations and Syllabus document produced as 
a pamphlet and also published in Th e Pharmaceutical 
Journal on 2 August 1919 provides full details of the 
course. Th e eligibility regulations were stringent: before 
starting the course, students must have already passed 
examinations in English, maths (arithmetic, algebra 
and geometry) and two other optional subjects set by a 
specifi ed shortlist of acceptable examination boards 
which included the Central Welsh Board (Junior Cer-
tifi cate), Oxford Junior, Cambridge Junior, London 
Matriculation or Welsh Matriculation.
A prospective student then had to apply for registra-
tion to the PSGB and spend not less than two years (or 
4,000 hours) in a pharmacy controlled by a ‘duly qual-
ifi ed pharmacist’. Th e national guidelines laid down 
that this could be either wholly in retail, or half and 
half in retail and a hospital setting. Following this, they 
must spend at least 300 hours studying chemistry, 60 
hours of botany and 60 hours of physics at an institu-
tion approved by PSGB before being entered for the 
Part I examination.
As part of the recent re-launch of the courses, the 
PSGB Council had newly devised these preliminary 
scientifi c syllabuses to bring them in line with fi rst year 
courses at university level so that the pharmacy students 
could be hosted by existing science departments. If stu-
dents chose to continue to take the Part II examination, 
they must fi rst attend a course of study of 720 hours in 
pharmacy and materia medica at an approved institu-
tion, and must also be at least 21 years old.10 Th e rec-
ommendation from Cardiff  Technical College, given 
in their 1921-22 prospectus, was that during the two 
years spent in a pharmacy, a student should take advan-
tage of any local courses in chemistry, botany and phys-
ics before proceeding to the full-time course, taking 
Part I in the fi rst year and Part II in the second year. 
Th e prospectus suggested
Th is plan of study will enable the student to fully 
grasp the work laid down in the syllabus instead of 
attempting to cram the work into the all-too-few 
hours laid down by the Society. He will thus become 
a trained Chemist who should easily pass the Qual-
ifying Examinations.11
Figure 1. Extract from the new Qualifying Examination 
Regulations & Syllabus, 1919 (Source: Royal Pharmaceu-
tical Society Museum, UK)
Of course, full-time attendance for two years was a lux-
ury that many aspiring pharmacists could not aff ord, 
and for some returning servicemen it was not necessary. 
Colleges, such as Cardiff  and Portsmouth, also off ered 
part-time courses. In Cardiff  these ran on Mondays and 
Fridays from 2:30pm to 5pm and covered pharmacy, 
materia medica, practical dispensing and Latin, and 
were linked to Part II of the PSGB’s examination ‘ar-
ranged for apprentices and junior assistants in order 
that they may obtain additional practice in dispensing, 
etc, to that of the Pharmacy and also to thoroughly un-
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derstand the theory underlying the operations’.12 Today 
we might call it a ‘day release’ scheme.
However, the prospectus is clear that simply attend-
ing these two sessions each week alongside an appren-
ticeship may not be enough: ‘At the same time it is nec-
essary to point out to the student that he should take 
advantage of one or more of the Evening Classes in 
Chemistry, Botany and Physics in order that he [sic] 
may more easily understand the principles of the prac-
tice of Pharmacy’. Th e student also had to invest in rel-
evant equipment: ‘Students are expected to purchase a 
box of Dispensing apparatus at a cost of £1 10s 0d, 
[£1.50] and also to provide themselves with suitable 
note-books’.13
Th e schools in Cardiff  and Portsmouth also off ered 
the Apothecaries’ Hall examination. Th is qualifi cation 
for assistants or dispensers, which had been established 
by the Society of Apothecaries after the Apothecaries’ 
Act of 1815, was particularly popular with women stu-
dents who found that this role was an acceptable one at 
a time when a female pharmacist, especially working in 
retail, could be controversial. Women pharmacists in 
this period still faced signifi cant prejudice from both 
male and female customers if they worked behind the 
pharmacy counter, and gaining any kind of business 
experience was almost impossible.14
Th e Apothecaries’ course comprised pharmacy, ma-
teria medica and chemistry,15 and was less academic 
than the PSGB qualifi cations, especially for students 
who did not aspire to own their own business. Interest-
ingly, the 1921-22 Cardiff  Technical College prospectus 
promotes the course purely for female students within 
a separate section headed ‘Women Dispensers’.16 With 
other sources such as photographs and speeches indi-
cating that a signifi cant proportion of woman students 
were enrolling in the main PSGB courses at the school, 
this gendered section seems out of touch. In fact, at the 
Cardiff  school’s offi  cial opening, the Lord Mayor noted 
that he was ‘delighted to see that young women had the 
same opportunities as the men’.17 Without surviving 
student records for this early period, it is diffi  cult to 
know whether there were also any men taking the 
Apothecaries’ examination.
For those not in receipt of a Government grant the 
fees varied between schools. Fees for the full-time 
courses were £15 15s (£15.75) in Cardiff  and Swansea 
(worth about £850 in today’s money) and £10 10s in 
Portsmouth. In Cardiff , it was £3 3s (£3.15) for the 
part-time course (about £170 today) for students from 
Cardiff  and Glamorgan, or 6 guineas (£6.30) for stu-
dents outside these areas, and £15 15s (£15.75) for the 
Apothecaries’ Hall course. Cardiff  Technical College 
also charged an additional £1 fee for apparatus and a 
£1 deposit to cover breakages.18
Th e schools of pharmacy
Th e full list of approved schools was given for the fi rst 
time in August 1920.19 Th irteen were permitted to 
teach Part I only, and ranged from Sheffi  eld University 
and Southampton University College to West Ham 
Municipal Technical Institute and even Wiggeston 
Grammar School in Leicester. Th e 25 approved to teach 
both Part I and Part II consisted predominantly of uni-
versities, university colleges and technical colleges in-
cluding those in Aberdeen, Birmingham, Brighton, 
Dundee, Edinburgh, Exeter, Glasgow, Leicester, Man-
chester, Newcastle, Nottingham and Sunderland.20 
Some were already well-established such as Manchester 
University, which already off ered the Qualifying, Ma-
jor and Degree routes into Pharmacy. Nevertheless, in 
the educational listings of Th e Chemist and Druggist in 
August 1919, it announced ‘A new laboratory with thir-
ty-six extra benches will be ready in October’.
Others off ered the Qualifying examination course 
for the fi rst time, including Cardiff , Portsmouth and 
Figure 2. Th e Society of Apothecaries Assistant’s Examina-
tion, 1919 (Source: Society of Apothecaries Archives, UK)
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Swansea. In the 1919-20 academic year the PSGB al-
located 1,400 students to pharmacy courses, and 1,500 
to colleges in 1920-21. Th is still left more than 1,000 
men without a place. Instead the PSGB established ‘the 
homework scheme’ where students were provided with 
three or four books, and they could then sit for the So-
ciety’s examination in these subjects. Speaking at the 
opening ceremony for Cardiff ’s new school of pharma-
cy on 8 October 1919, the Lord Mayor stated: ‘We must 
do all we can to help the men who found security for 
us in the time of strife and danger we had just been 
through’.21 
Portsmouth
In the August 1919 educational listings in Th e Chemist 
and Druggist, Portsmouth Municipal College listed a 
college principal and head of the chemistry department, 
but a vacancy for the post of lecturer on pharmacy. 
Nevertheless, it stated
It is hoped to arrange courses for the Qualifying Ex-
amination of the Pharmaceutical Society and for as-
sistants to apothecaries. Th ere will be separate cours-
es for day and evening students.22
Th e roots of formal pharmacy education in Portsmouth 
go back to the early 1900s and the Portsmouth Munic-
ipal Technical Institute, at which part-time classes in 
pharmacy and dispensing began in 1906, alongside 
classes in physics, chemistry and botany, promoted as 
ideal for prospective pharmacy students wanting to pass 
the PSGB initial Preliminary Examination.
Th e pharmacy course was led from 1910 to 1914 
by Elsie Hooper (later Higgon) (1879-1969), having 
already achieved success in the PSGB Minor and Ma-
jor examinations, and graduating with a BSc in bota-
ny and chemistry from London University in 1905. 
She also served as the fi rst Joint Secretary of the (Na-
tional) Association of Women Pharmacists, and 
Figure 3. Portsmouth Municipal 
College and Town Hall (Source: 
undated postcard)
Figure 4. Elsie Hooper, c.1905 (Source: Royal Pharma-
ceutical Society Museum, UK)
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worked as a researcher for King’s College, the British 
Medical Journal and the British Pharmaceutical Codex 
before taking up the post in Portsmouth.23 Whilst 
working at the college she attended at least one suf-
frage march in London.24 
In June 1919 an advertisement appeared in Th e 
Chemist and Druggist for a lecturer in the chemistry de-
partment who was also expected to teach pharmacy 
with a starting salary of between £200 and £250 with 
progression at £25 p.a. to a maximum of £350.25 Mr F. 
Hemming was appointed senior lecturer in pharmacy 
at a salary of £260 p.a., with the Portsmouth Education 
Committee minutes stating
Correspondence was submitted showing that the So-
ciety [PSGB] desired to know if the Committee 
could accommodate 25 ex-service students under 
the Government Scheme of Training, and stating 
that the Council were prepared to recognise the Col-
lege as an approved Training Centre.26
By August 1920 Portsmouth was off ering a full-time 
course for the Qualifying examination and a part-time 
one for apothecaries’ assistants, alongside separate even-
ing classes.27
Cardiff 
Local support was also key to the establishment of the 
pharmacy school in Cardiff . On Friday 10 October 
1919, Th e Times ‘News in Brief ’ column simply report-
ed ‘Cardiff  now has a College of Pharmacy’. Th e fol-
lowing week, Th e Pharmaceutical Journal carried a 
much more detailed article reporting the offi  cial open-
ing of the college by the Right Honourable Lord May-
or of Cardiff , on Wednesday 8 October 1919. Sir Wil-
liam Glyn-Jones, the PSGB’s Secretary and Registrar, 
gave the inaugural address, and the event was chaired 
by Councillor F.W. Blake, Chairman of the Technical 
Instruction Committee ‘supported by several infl uen-
tial gentlemen’. Also present were members of the Car-
diff  Chemists’ Association, and the South Wales and 
Monmouthshire Local Associations Federation de-
scribed as ‘largely instrumental in bringing this great 
project to a successful beginning’.29
Th is was certainly true. Reports from the pharmacy 
press show that excitement had been building about the 
college’s opening amongst gatherings of Welsh phar-
macists. In February 1919 the Carmarthenshire Chem-
ists’ Association held ‘interesting discussions’ about the 
new pharmacy school ‘for Wales’ in Cardiff .30 In 
March, pharmacist Alfred Hagon gave a ‘chatty and 
entertaining lecture’ to the Cardiff  Rotary Club includ-
ing information about the scheme to open the school 
of pharmacy in September.31 Later accounts ascribe the 
original idea for a pharmacy school in Cardiff  to Mr 
Hagon.32
Th e South Wales Federation elected an advisory 
committee to work with PSGB Council member Major 
Ernest Saville Peck to establish ‘a course of action in 
reference to the instituting of the National College of 
Pharmacy for Wales’. Th e committee’s membership re-
fl ected the commitment to make it more than a school 
for Cardiff  with representatives from Carmarthen, 
Figure 5. Staff  vacancies, Portsmouth Municipal College, 
1919 (Source: Th e Chemist and Druggist, 28 June 1919)
Figure 6. Th e New Technical College, Cardiff , from its 
1921-2 prospectus (Source: Glamorgan Archives)
Th e pharmacy course was strongly supported by the lo-
cal pharmacy community, with the off er in April and 
May 1920 from ‘four pharmacists of the town who 
wished to remain anonymous’ of two silver and two 
bronze medals as competition prizes for students of the 
pharmacy classes attended by ex-service men. From the 
fi rst cohort, war veteran Leslie Henry Harlow received 
the Queensboro medal for pharmacy, materia medica 
and dispensing from the Portsmouth Municipal Col-
lege on 16 July 1920.28
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Pembrokeshire, Merthyr, Swansea and Rhondda as well 
as pharmacists from Barry, Mid-Glamorgan and Car-
diff  itself.33
for a second lecturer, at a salary £50 less than Mr Lew-
is’s role. With plans to staff  the new department in 
place, the advisory committee ‘were instructed’ to or-
ganise the opening day in October.35 At the school’s 
opening, aspirations were justifi ably high. It was re-
ported that Councillor Blake stressed that ‘
No eff ort on his Committee’s part would be lacking 
to make this School of Pharmacy rank highest in the 
country. It rested also with the students themselves. 
Th ey were not catering for Cardiff  alone, but for the 
whole of Wales. Th e lecturers obtained were of the 
best, and appointed by his Committee in consulta-
tion with chemists themselves. Th ere was every pos-
sibility of the School being a great success.36
Sir William Glyn-Jones raised the stakes even high-
er, telling the students:
It was their privilege to be educated at the Welsh 
College of Pharmacy, and they were the fi rst students 
who would set the traditions of the College so high, 
he hoped, that in after years to be able to say that 
one was educated at the Welsh College of Pharmacy 
would do much to secure a berth in advance of oth-
ers not so fortunate.37
Th e fi rst year intake appear to have met the required 
standard with reports in late July 1920 of examination 
passes for Cardiff -based students including W.C. Nich-
olas for the Qualifying Examination, and J.M. Davies 
and W.V. Niblett for Parts I and II examinations.38
Figure 7. Lecturer vacancy, Th e Technical College, Cardiff , 
1919 (Source: Th e Chemist and Druggist, 31 May 1919)
By May 1919 a pharmacists’ committee had met with 
the Cardiff  Technical Committee, and an advertise-
ment for a ‘full-time lecturer’ post appeared in Th e 
Chemist and Druggist on 31 May 1919 and again on 7 
June. On 12 July it was reported
Mr Th omas Lewis, PhC, FSMC, manager with 
Boots Ltd at Wine Street, Bristol, has been appoint-
ed Lecturer in Pharmacy in the new department at 
the Cardiff  School of Technology.34
Although it was not stated in these terms, Lewis’s posi-
tion was that of head of school. In the same edition of 
Th e Chemist and Druggist there was an advertisement 
Figure 8. Th e fi rst cohort of students and staff  in Cardiff , 1920 (Source: School of Pharmacy and Pharmaceutical Sci-
ences, Cardiff  University, UK. Published in Th e Chemist and Druggist, 21 August 1920)
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Th e pharmacy students were taught by both dedi-
cated staff  and those from other Technical College de-
partments. Joining Mr Lewis as his assistant and lec-
turer in pharmacy, materia medica and Latin, was Mr 
F.C. Highfi eld. Mr Rudge, BSc, was also listed in the 
fi rst year as lecturer in botany and chemistry, and 
Th omas Jones as lecturer in physics. By August 1920, 
Mr H. Aldred, MSc, had joined Mr Rudge in physics, 
and Miss Margaret L. Andrews, MSc, had joined Mr 
Jones in botany. Th e school was clearly meeting a need, 
as the piece ended: ‘All the benches for the next session, 
which will commence on October 5, have been allot-
ted’.39
At the start of the 1920-21 academic year Charles 
Coles, Principal of the Technical College, gave an over-
view of the School’s activities for the previous year, giv-
ing ‘great praise to Messrs Lewis and Highfi eld’. He 
started with a breakdown of student numbers: 63 full-
time students, including 53 ex-servicemen, were work-
ing for the Minor examination; 12 full-time students 
on the Apothecaries’ Hall examination course; and 13 
part-time attending 3 afternoons each week. Th e total 
of 88 students represented maximum capacity for the 
college. Looking ahead to the following academic year, 
there were 51 full-time students on the Minor course, 
including 41 ex-servicemen, 12 Apothecaries’ Hall stu-
dents, and 10 part-time students. In the fi rst year, 21 
students had passed Parts I and II of the PSGB Quali-
fying examination and were now pharmacists. Sixteen 
had passed Part I.40
Dr Arbour Stephens, of Swansea, is endeavouring to 
get a pharmacy department established in connec-
tion with the Swansea Training College. Th e idea is 
to train ladies to act as dispensers.41
Although Swansea was defi nitely on the pharmacy map, 
having hosted the British Pharmaceutical Conference in 
1880, its progress towards a pharmacy school was no 
swifter than in Cardiff . Again, the catalyst was obvious:
It is a remarkable fact that the majority of applica-
tions for appointments and student courses from ex-
service offi  cers relate to pharmacy and there has been 
a spec[ial?] glut of these applications at Swansea.42
By August 1919 Th e Chemist and Druggist included the 
Swansea school in its annual educational listings, with 
staff  listed from the chemistry, physics and botany de-
partments as well as Mr W.T. Siverstsen, chemist and 
druggist, as the member of staff  for pharmacy.43 How-
ever, the advertisement for a lecturer at the school to 
teach the PSGB Minor examination syllabus (£350 
p.a.) suggests that arrangements were not yet in place 
to welcome the students.
Nevertheless, the school opened on 7 October 1919 
at the Municipal Technical College, Mount Pleasant, 
Swansea. Mr S.A.W. Rushbrooke, PhC, is listed in con-
temporary reports as lecturer in pharmaceutics, with 
Mr E.A. Tyler as head of chemistry.44 Like its Cardiff  
and Portsmouth equivalents, the school received sig-
nifi cant support from the local pharmacy community. 
Th e Swansea and West Glamorgan Chemists’ Associa-
tion presented a silver and bronze medal each year to 
high-performing pharmacy students.45 In 1921 the 
school is styled the ‘West Wales College of Pharmacy’ 
in Th e Pharmaceutical Journal.46
Th e existence of two pharmacy schools in South 
Wales prompted almost immediate debate, initiated by 
the advisory committee of the Welsh College of Phar-
macy in Cardiff . Th ey passed a formal resolution in 
October 1921 ‘that the Pharmaceutical Federation be 
asked to consider the question of the advisability of con-
tinuing two Schools of Pharmacy in Wales’. At the 
South Wales and Monmouthshire Local Pharmacy As-
sociation Meeting in Neath on 9 February 1922, this 
resolution ‘caused a very animated discussion…’ How-
ever, the pragmatic decision was made not to take any 
hasty action, as the question would arise again – once 
the glut of ex-service students were trained – as to 
whether the Swansea and Cardiff  schools would both 
be able to carry on, and then it would be for the local 
authorities to decide.47 By 1923 the intake of ex-service-
men was over, and the schools entered a new phase.
Figure 9. Course advertisement, Th e Technical College 
Swansea, 1919 (Source: Th e Chemist and Druggist, 11 
October 1919)
Swansea
For nearly a decade, there were two schools of pharma-
cy in South Wales. On 17 May 1918 Th e Cambria Dai-
ly Leader reported
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Th e following decades
During the 1920s all three schools appeared to go from 
strength to strength. In Portsmouth in 1922, a course 
for the Pharmaceutical Chemist (PhC) Diploma was 
organised. In 1925 the Cardiff  School ran this same 
PSGB Major course for the fi rst time, and Swansea in-
troduced it in 1926. Both the Portsmouth and Cardiff  
schools received recognition from the University of 
London to teach that university’s external Bachelor of 
Pharmacy degree in 1927.
However, in June 1929 Swansea’s head of school, 
Harold Davis, was appointed chief pharmacist to Uni-
versity College Hospital, London (he went on later to 
become chief pharmacist at the Ministry of Health). 
On Mr Davis’s departure Mr Andrew James Th orburn, 
PhC, had been appointed head of pharmacy. However, 
at a meeting of the Swansea Higher Education Com-
mittee on 2 December 1929 it was reported that the 
director of education had received a letter from the 
PSGB secretary questioning Mr Th orburn’s salary in 
the light of the recent Burnham Report.48
Th e Society stated that the head of school should be 
paid no less than £500 p.a., and that the school would 
not be recognised offi  cially for its Qualifying examina-
tion unless this was complied with. Swansea Education 
Committee responded that no other society sought to 
prescribe terms for its members, and suggested that 
such action would mean that colleges would be reluc-
tant to develop professional courses. Th e Committee 
also reminded PSGB that the maintenance of the phar-
macy department was an advantage to PSGB as well as 
to the general public.49
Th ere seemed to be no mood for reconciliation, and 
a letter from the PSGB dated 7 December 1929 an-
nounced the withdrawal of the Society’s recognition of 
the College as an institution to take the Qualifying ex-
amination after 31 July 1930.50 It was reported in Th e 
Pharmaceutical Journal on 13 September 1930 that a 
last ditch eff ort to maintain the department had been 
unsuccessful. An ‘agitation’ by the Labour section of 
Swansea Council led to the agreement that the salary 
would be set at the £500 demanded by PSGB. How-
ever, the article concluded
Th e letter now received from the Society [PSGB] re-
grets that Swansea’s decision has come too late for 
the Society to alter its refusal to recognise the Swan-
sea College.51
So, whilst in October 2019 the pharmacy schools in 
Cardiff  and Portsmouth are celebrating 100 years of 
pharmacy education in their cities, in Swansea – nine-
ty years after the last pharmacy students qualifi ed – a 
new pharmacy department is being established as part 
of Swansea University.52
Conclusion
In 1919 a combination of factors combined to create a 
step-change in British pharmacy education. Th ese were, 
fi rstly, the national imperative created by signifi cant 
numbers of demobilised men keen to grasp the oppor-
tunity of government funding for professional training. 
Secondly, the chance seized by the Pharmaceutical So-
ciety of Great Britain to use the new circumstances to 
implement the long overdue national codifi cation and 
control of pharmacy educational facilities and curricu-
la, which had been promised by the 1908 Pharmacy 
Act. Th irdly, the changes were given greater impetus 
and were augmented by the impact on retail pharmacy 
of the delayed comprehensive implementation of the 
National Health Insurance scheme. Fourthly, the avail-
ability and willingness of existing institutions to deliv-
er pharmacy courses. And fi fthly, the enthusiastic sup-
port available from the local pharmacy communities, 
who were keen to see their profession prosper and de-
velop.
Acknowledgements
Th e author would like to thank Professor Darek Gore-
cki (Portsmouth University) for generously sharing his 
research and enthusiasm. Th e staff  at Cardiff  Univer-
sity Special Collections and Archives, Glamorgan Ar-
chives, the Royal Pharmaceutical Society Museum and 
Library, and the Worshipful Society of Apothecaries’ 
Archives have all helped to provide access to their col-
lections and expertise. Th ank you to James Waldron, 
Editor of Chemist+Druggist, for permission to publish 
historical images from the journal.
Author’s address: Briony Hudson, Th e Coppins, New 
Road, Princes Risborough, Bucks, HP27 0LA, UK. 
Email: brionyhudson@hotmail.com
Endnotes and References
1. Quoted in Holloway, SWF. Royal Pharmaceutical Soci-
ety of Great Britain 1841-1991. A Political and Social History. 
London: Th e Pharmaceutical Press, 1991, 355.
2. https://encyclopedia.1914-1918-online.net/article/vet-
erans_associations_great_britain_and_ireland. Accessed 6 Feb-
ruary 2019.
3. Peck, Saville E. A Survey of Pharmaceutical Education 
from 1910. Pharmaceutical Journal. 4 May 1935: 134.
4. Training Demobilised Men. Th e Chemist and Druggist. 
21 April 1919: 63.
5. Th e Chemist and Druggist (Note 4) 1919: 63.
6. Holloway, SWF. (Note 1) 1991: 355.
7. Holloway, SWF. (Note 1) 1991: 355.
8. Th e Chemist and Druggist. 21 August 1920: 1182.
https://doi.org/10.24355/dbbs.084-202007300934-0
 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/4 105
9. Hudson, B. and Boylan M. Th e School of Pharmacy Uni-
versity of London: Medicines, Science and Society. London: Aca-
demic Press, 2013: 86.
10. Pharmaceutical Society of Great Britain, Regulations for 
the Qualifying Examination (undated pamphlet).
11. City of Cardiff  Education Committee, Th e Technical 
College Abridged Prospectus for Session 1921-22. 1921: 108.
12. City of Cardiff  Education Committee (Note 11) 1921: 
36.
13. City of Cardiff  Education Committee (Note 11) 1921: 
37.
14. Women in British Pharmacy. A War-time Demonstra-
tion and Review. Th e Chemist and Druggist, 29 July 1916: 790-1.
15. Society of Apothecaries of London Assistant’s Examina-
tion syllabus 1919.
16. City of Cardiff  Education Committee (Note 11) 1921: 
108.
17. Cardiff : Opening of the Welsh College of Pharmacy. 
Pharmaceutical Journal. 18 October 1919: 347.
18. Th e Chemist and Druggist. 16 August 1919: 910.
19. Th e Chemist and Druggist. (Note 8) 1920: 1182.
20. Peck, Saville E. (Note 3) 1935: 134.
21. Pharmaceutical Journal. (Note 17) 1919: 347.
22. Th e Chemist and Druggist. (Note 18) 1919: 910.
23. Shellard, EJ. Some early women research workers in 
British pharmacy 1886-1912. Pharmaceutical Historian. 1982; 
12(2): 2-3.
24. Th e Chemist & Druggist. 25 March 1911: 443.
25. Th e Chemist & Druggist Supplement. 28 June 1919: lx-
viii.
26. Portsmouth Municipal Council. Education Committee 
minutes (CCM21/7+8), July 1919.
27. Th e Chemist and Druggist. (Note 8) 1920: 1184.
28. Personal correspondence with Prof Darek Gorecki.
29. Th e Pharmaceutical Journal. (Note 17) 1920: 347.
30. Minute book of the South Wales and Monmouthshire 
Pharmacists Local Associations Federation. 5 October 1922.
31. Th e Chemist and Druggist. 29 March 1919: 49.
32. Th e Chemist and Druggist. 9 December 1922: 82.
33. Th e Chemist and Druggist. 31 May 1919: 63.
34. Th e Chemist and Druggist. 12 July 1919: 52.
35. Th e Chemist and Druggist. 9 August 1919: 65.
36. Pharmaceutical Journal. (Note 17) 1920: 347.
37. Pharmaceutical Journal. (Note 17) 1920: 347.
38. Th e Chemist and Druggist. 31 July 1920: 60-1.
39. Th e Chemist and Druggist. (Note 8) 1920: 1182.
40. Minute book of the South Wales and Monmouthshire 
Pharmacists Local Associations Federation. 9 September 1920.
41. Th e Cambria Daily Leader. 17 May 1918: 1.
42. Th e Cambria Daily Leader. 14 May 1919: 1.
43. Th e Chemist and Druggist. (Note 18) 1919: 910.
44. Pharmaceutical Journal. 2 April 1921: 261.
45. Th e Cambria Daily Leader. 18 November 1919: 1.
46. Pharmaceutical Journal. (Note 44) 1921: 261.
47. Minute book of the South Wales and Monmouthshire 
Pharmacists Local Associations Federation. 9 February 1922.
48. https://discovery.nationalarchives.gov.uk/details/r/
C822. Accessed 6 February 2019.
49. Th e Chemist and Druggist 14 December 1929: 703.
50. Th e Chemist and Druggist. (Note 49) 1929: 703.
51. Pharmaceutical Journal. 13 September 1930.
52. https://www.swansea.ac.uk/press-off ice/news-ar-
chive/2018/swanseauniversitymedicalschoolappointsheadofp-
harmacytolaunchnewcourse.php Accessed 6 February 2019.
https://doi.org/10.24355/dbbs.084-202007300934-0
106 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/4
A R T I C L E
An historical and chemical study of 
Samona brand tablets: A tonic available in 
the United Kingdom from the late 1930s
Andrew Hardy and Gavyn Rollinson
Abstract
Two medicinal tonics, Samona brand tablets No. 1 
(for men) and Samona brand tablets No. 2 (for wom-
en), were available in the United Kingdom from the 
late 1930s. Th is article presents historical and some 
initial chemical data on these tablets. Th ey were ini-
tially well advertised, mostly in the weekly trade mag-
azine, Th e Chemist and Druggist. Some reasonably de-
tailed compositional data was given on their 
containers. Our historical data, and to a lesser extent 
our chemical data, indicate that these tablets con-
tained various crushed and dried whole glands (or 
glandular extracts) and so were perhaps intended as 
‘aphrodisiac/rejuvenation tonics’, in addition to their 
use as a general tonic. 
Introduction
In the fi rst half of the twentieth century in the United 
Kingdom there were a multitude of tonics available to 
the paying public. Th ey could be mildly restorative en-
ergy drinks containing sugar or small amounts of alco-
hol; or stronger ones containing caff eine, larger amounts 
of alcohol or a variety of herbal extracts; or a few that 
contained potentially toxic/addictive substances such 
as amphetamines and opiates. 
When tonics were sold as ‘popular medicines’, they 
were often described at this time in the United King-
dom as nostrums, patent medicines or proprietary med-
icines. Th ere were also the so-called ‘quack’ medicines, 
which were made and sold by so-called ‘quack doctors’– 
who were usually regarded as charlatans or mounte-
banks by the medical profession.1 
Nostrums were medicines made up from a book of 
recipes belonging to a community apothecary, chemist 
and druggist or pharmacist. A patent medicine was one 
whose details of manufacture and composition had 
been protected in law by obtaining ‘letters of patent’ 
from the government for a fee. However, this veneer of 
associated respectability was often undermined by min-
imal or meaningless information being given, and by 
the reluctance of the authorities to strictly enforce the 
law. 
Th us many patent medicines were often regarded as 
‘quack’ medicines. A proprietary medicine was one sold 
under a brand name, which was often trademarked. 
Sometimes they were also patented (or claimed to be). 
Th ey could be purchased freely as over-the-counter 
medicines, and were sometimes prescribed by a regis-
tered medical doctor. Overall this gave rise to ‘secret 
remedies’, whose composition was eff ectively unknown; 
and to ‘non-secret remedies’, where compositional data 
was given on the medicine’s container or associated leaf-
let.2, 3 
By the fi rst decade of the twentieth century the Brit-
ish Medical Association (BMA) had become concerned 
over the public’s increasing use of ‘popular medicines’. 
Th ey therefore decided to have some of them chemi-
cally analysed and the results published. Overall, sev-
eral hundred such medicines were analysed, and in 
1909 a book containing some of the results was pub-
lished (Secret Remedies: what they cost and what they con-
tain). More analytical results were published in a second 
book published in 1912: More Secret Remedies: what they 
cost and what they contain. Th is second book includes a 
chapter entitled ‘Nerve Tonics and Elixirs of Life’.4 Two 
examples of tonics mentioned in this chapter are given 
below:
1. Guy’s Tonic was a red liquid prepared and sold by a 
London fi rm. Its associated leafl et said it could be 
used for a whole range of ailments, which included 
as a tonic. It was found to contain: small amounts 
of cochineal colouring, hydrochloric and phosphor-
ic acids and alcohol; and significantly larger 
amounts of chloroform water and compound infu-
sion of gentian (an infusion of the bitter extract of 
gentian root).
2. Damaroids were pills, again prepared and sold by a 
London fi rm, but having a somewhat less eff usive 
list of ailments that they could cure. Th e pills were 
sugar-coated and otherwise consisted of (in increas-
ing % presence) quinine sulphate, iron hypophos-
phite, talc and an ‘extract’ (thought probably to be 
Damiana – the leaf extract of the shrub Turnera 
diff usa).
Th ough thousands of these books were sold, such 
medicines continued to be used, and they were often 
heavily advertised. A brief survey by us of the weekly 
trade magazine Th e Chemist and Druggist (C&D) 
from the late 1930s to the early-to-middle 1940s gives 
many proprietary medicine advertisements.5 Some 
were for various types of tonics, and a few examples 
are as follows:
1. Th e glucose-containing carbonated energy drink 
Lucozade.
2. Liquid and pills of ‘Phosferine: A tonic restorative 
after winter ailments’. Th e liquid was analysed and 
the results given in the above mentioned 1912 book. 
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Its composition was given as – in increasing parts 
by measure – quinine sulphate, diluted sulphuric 
acid, alcohol and diluted phosphoric acid.6 
3. Th e ‘reconstructive tonic’ syrup Minadex. It was 
said to contain vitamins A and D, plus iron, calcium 
and other essential tonic minerals. 
4. Manoids, which were described as ‘the potent brain 
and nerve tonic for men’. Th is advertisement is 
much smaller than for the three above, and only 
gives the above statement about itself, plus its price 
and an address in Surrey. 
Mention should also be briefl y made of ‘aphrodisiac 
tonics’. Such tonics at this time sometimes contained 
crushed and dried whole glands and/or glandular ex-
tracts (both usually bovine). Th eir perceived active in-
gredients were usually the various hormones produced 
by specifi c glands. Th ese hormones, often the male/fe-
male sex hormones, were being isolated with increasing 
purity at this time. Th ey were sometimes listed as a 
tonic’s component or as separate materials to be admin-
istered directly. 
An example of a Chemist and Druggist advertise-
ment from 1943 for purchasing the sex hormones 
themselves is for the ‘Sublingual Administration of 
the Sex Hormones…’ in the form of Linguets (this last 
word being said to be trademarked). Th ree types of 
pills were listed, where each were said to contain a dif-
ferent, orally active hormone derivative.7 No uses were 
given in the advertisement, but two previously pub-
lished medical papers were mentioned. Th ese papers 
give information on the positive results obtained when 
two of the advertised hormone derivatives were clini-
cally tested.8, 9 
Th e origins of Samona brand tablets
Th e Company known as ‘Samona Ltd’ was set up in 
London in April 1938 by a Mr James Dunn (1879-
1960). On the company records10 he is listed as com-
pany director and ‘chemist’, with a residential ad-
dress in Newton-Stewart, Dumfries, Scotland. Th e 
company’s initial address was given – in its advertise-
ments and on our bottle’s label for the No. 1 (for 
men) tablets (Figure 1) – as 16 (sometimes 16-18) 
Charterhouse Street, London, E.C.1. Th e address 
given in the advertisements changed to Northington 
House, Northington Street, London, W.C.1, from 
October 1941. Th is address was on our bottle’s label 
for the No. 2 (for women) tablets; implying that our 
‘No. 1’ samples were made and marketed fi rst (i.e. 
between spring 1938 and autumn 1941) and that our 
‘No. 2’ samples came later (i.e. from autumn 1941 
onwards). 
Mr James Dunn was a registered chemist and drug-
gist, and was fi rst registered as such with the Pharma-
ceutical Society of Great Britain in April 1901. He was 
a community pharmacist with a shop in Newton-Stew-
art, Dumfries (where its exact address was the same as 
that given in the above Company’s records), from which 
he retired in 1947. He had resigned from Samona Ltd 
in February 1943. Th e Company changed ownership 
and location several times over the following decades, 
as did the stated recipe for the Samona brand tablets 
(see below). Th e Company was fi nally dissolved in 
1982. 
Th e fi rst advertisement for these tablets appeared in 
the trade magazine Th e Chemist and Druggist was in the 
issue of 7 May 1938. Th e fi rst mention of the existence 
of separate tablets for men and women in the advertise-
ments was in the issue of 18 June 1938. Th is informa-
tion was retained in the advertisements until the end of 
June 1940. Th e tablets were heavily advertised in Th e 
Chemist and Druggist initially, and Samona brand tab-
lets were one of its top twenty most advertised products 
of 1938. 
In all the advertisements there is given – in varying 
amounts of detail – a list of ailments that the tablets 
‘cured’. For example, in Th e Chemist and Druggist issue 
of 6 April 1940, it is stated that a Samona brand tablet 
‘…brings immediate relief in all cases of nerve strain, 
depression, sleeplessness, tired and listless appearance, 
mental and physical exhaustion’. Th e number of adver-
tisements slowly decreased into the early to middle of 
the 1940s, and by 1948 they were being much less ad-
vertised. 
Recipes for Samona brand tablets were fi rst listed in 
Martindale’s Extra Pharmacopoeia in volume II of the 
twenty-second edition published in 1943.11 Th e recipe 
given for the ‘No. 2 (for women)’ tablets was identical 
to that found on the label of our bottle (see later, Table 
4). Th e recipe for ‘No. 1 (for men)’ tablets was diff erent, 
and is given in Table 1, along with the amounts per tab-
let and an interpretation for each ingredient. Note that 
a grain (gr.) is 64.8 mg and a minim (min.) is 0.0591 
ml. We have been unable to determine the meaning/
amount of a ‘unit’ as described here. Both recipes had 
a daily dosage of one tablet listed. 
Th e two recipes were next mentioned in volume II 
of the twenty-third edition of Martindale’s Extra Phar-
macopoeia published in 1955.12 However, these tablets 
were listed as being manufactured by the Camden 
Chemical Co. of 61 Gray’s Inn Road, London, W.C.1. 
Th e recipe for ‘No. 1 (for men)’ is given in Table 2, 
again with the amount per tablet and with an interpre-
tation of each ingredient.
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Table 1. Contents of Samona brand tablets No. 1 (for 























1/3 of a grain Powdered red 
cinchona bark
Tr. Iode. Fr. 
Cod. 
1/30 of a minim Tincture of 
iodine, as 
described in the 
Offi  cial French 
Codex, i.e. the 
French 
Pharmacopoeia 
Excipient q.s. ‘Quantum 
suffi  cit’, that is 
‘as much as 
suffi  cient’
Table 2. Contents of Samona brand tablets No. 1 (for 
men) in 1955 (Source: Martindale)
Ingredient Quantity Explanation
Strychnine 0.002 grain An alkaloid




Soft extract of 
kola 
1.000 grain From the dried 
cotyledons 
(seed leaves) of 




ent is caff eine
Glycyrrh. Pulv. 1.000 grain Powdered 
liquorice root
Vitamin B1 0.003 grain
Vitamin A 100 i.u.
Vitamin D2 10 i.u. 
Th e recipe given for ‘No. 2 (for women)’ is as listed in 
Table 2, with an additional ingredient of 50 i.u. of stil-
boestrol (a synthetic female sex hormone). An interna-
tional unit (i.u.) is a small unit of weight or volume, 
which varies according to the biologically active sub-
stance being discussed.13 
Whilst these two (1955) recipes contain two known 
stimulants (caff eine and strychnine), they do not con-
tain any whole glands or glandular extracts. One con-
tains a small amount of a synthetic female sex hormone. 
Given the above, and that they were not made or mar-
keted by Samona Ltd, we will not discuss them further. 
Th ere is no mention of Samona brand tablets in the 
twenty-fourth (1958/61, volumes I and II), twenty-fi fth 
(1967), twenty-sixth (1972) or twenty-seventh (1977) 
editions of the Extra Pharmacopoeia. No further edi-
tions were examined as Samona Ltd had been dissolved 
in 1982. 
Figure 1. SAMONA Brand Tablets No. 1 (for Men), bot-
tle and tablets (Source: Author-see acknowledgements) 
Samples and chemical analytical methods
Sample 1: Samona brand tablets No. 1 (for men) 
Th ese tablets are red-brown in colour and each weigh 
0.25 gm. Th ey are circular with a diameter of 8 mm 
and a uniform thickness of 2 mm. Using the weight of 
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our tablet and the ingredients’ percentages given in Ta-
ble 3 we have added in a separate column the amount 
of each non-excipient ingredient (in grams, gm) in one 
tablet. Th e tablets are in their original screw-top glass 
bottle, with labelling on its front and back (Figure 1). 
On the back label is given the dosage (one tablet three 
times a day, preferably before meals), the manufactur-
er’s company name and address (Samona Ltd, 16/16-18 
Charterhouse Street, London, E.C.1), and the words 
‘No proprietary right is claimed apart from the regis-
tered trade mark Samona’. Also, at the top of this label 
are the words ‘Samona Brand Tablets No. 1 (for Men)’. 
On the front label are the words ‘Makes Life Anew’, 
and in fi ner print some abbreviated compositional de-
tails are given. Th ese are reproduced in Table 3, along 
with an interpretation of each ingredient. 
Sample 2: Samona brand tablets No. 2 (for women)
Th ese tablets are dark brown in colour and each weigh 
0.29 gm. Th ey are circular with a diameter of 9.5 mm. 
Again we have added, after each ingredient’s percent-
age given in Table 4, the amount in one tablet. Th e tab-
lets were found in their original screw-top bottle (with 
labelling front and back), which was in its original box 
with a leafl et (Figure 2). 
On the back label of the bottle is given the same 
dosage as before and the same words regarding the trade 
mark name Samona, but with a diff erent address 
(Northington House, Northington Street, London, 
W.C.1). Also, at the top of this label are the words 
‘Samona Brand Tablets No. 2 (for Women)’. On the 
front label are again the words ‘Makes Life Anew’, and 
in fi ner print at the base of this label some abbreviated 
compositional details are given. Th ese are reproduced 
in Table 4, along with the interpretation of each ingre-
dient.
Table 3. Contents of Samona brand tablets No. 1 (for men) (Source: Sample 1 label)
 
Ingredient Percentage Approximate 
weight in gm
Explanation
Prostatine Sicc. 17.50 %  0.04380 gm Probably dried prostate gland
Didymin Sicc. 17.50 % 0.04380 gm Probably dried testes material/extract
Th ymus Sicc. 8.75 %  0.02190 gm Dried thymus gland
P. Cinch. Rub. 35.00 % 0.08750 gm Powdered red cinchona bark
Tr. Iode. Offi  cin. Fr. Cx. 1.75 % 0.00438 gm Tincture of iodine, as described in the Offi  cial 
French Codex, i.e. the French Pharmacopoeia
P. Glycyrrhizae 17.50 %  0.04380 gm Powdered liquorice root
Excipient to 100.00 %  i.e. 2%
Figure 2. SAMONA Brand Tablets No. 2 (for Women), 
bottle and tablets, with box and leafl et (Source: Park Phar-
macy Trust Collection, Plymouth, UK)
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Chemical analytical methods used 
Th e chemical analytical techniques used so far on our 
two samples have been QEMSCAN (Quantitative 
Scanning Electron Microscopy), XRPD (X-Ray Powder 
Diff raction) and a preliminary analysis on only one 
sample – No. 1 (for men) – using MS (Mass Spectrom-
etry). Th e fi rst technique does elemental analysis (down 
to and including carbon) and identifi es crystalline or 
amorphous inorganic/mineral compounds (or some-
times a group of compounds) present. Th e second tech-
nique can identify crystalline materials present, and the 
third technique the organic compounds.14, 15
Results
Results for Samona No. 1 (for men) tablets
QEMSCAN: one tablet was cracked open and data col-
lected on both the (powdered) inner and outer materi-
als. Elemental compositions are given in decreasing or-
der of weight percent, and where the elements in 
brackets are each present at less than 1%.
Inner material: O, C, Ca, Mg, Si, P (Al, F, Fe, K, 
Cl, Cu)
Outer material: O, C, Ca, Mg (Si, P, F, Al, Cu)
Th e presence of organic compounds makes quantitative 
calculations for the inorganic compounds identifi ed 
uncertain, and so only the most abundant compounds 
identifi ed are given (in decreasing order of their ap-
proximate percentage presence).
Inner material: Dolomite (calcium magnesium car-
bonate), Magnesium Silicates (such as Talc), Apatite 
(calcium phosphate), Calcite (calcium carbonate).
Outer material: Magnesium Silicates, Dolomite, 
Apatite, Calcite.
XRPD: One tablet was completely crushed to powder 
and the only crystalline material found was the sugar 
sucrose. 
MS: One tablet was crushed to powder and preliminary 
results showed the presence of two carboxylic (fatty) 
acids (stearic and palmitic), an unidentifi ed hydrocar-
bon, sucrose and two other sugar derivatives (perhaps 
glycosides). Also, the smaller hormone molecules (such 
as steroids) were searched for, and not found. 
Results for Samona No. 2 (for women) tablets
QEMSCAN (as above). Elemental compositions: 
Inner material: O, Fe, Si, Mg, C, Ca, Cu (P, F)
Outer material: O, Ca, Fe, Mg, C, Si, Cu (Pb, Zn, 
S, P, F)
Th e most abundant compounds identifi ed (as before):
Inner material: Magnesium Silicates, Iron oxide/
carbonate, Magnesite (magnesium carbonate), Cal-
cite. 
Outer material: Calcite, Magnesite, Magnesium Sil-
icates, Iron oxide/carbonate.
XRPD: One tablet was cracked open and data collected 
on both the inner and outer materials.
Inner material: Sucrose >> Talc > Calcite.
Outer material: Sucrose >> Calcite ≈ Talc.
It is hoped to use, in the future, the Gas/Liquid Chro-
matography – Mass Spectrometry (GC/LC-MS) 
technique(s) to obtain more detailed data on the (non-
sucrose) organic components of these two samples, and 
publish the results in a later article. 
Table 4. Contents of Samona brand tablets No. 2 (for women) (Source: Sample 2 label) 
Ingredient Percentage Approximate 
weight in gm
Explanation
P. Cinch. Rub. 35.00 % 0.10150 gm Powdered red cinchona bark
Tr. Iode. Offi  cin. Fr. Cx. 1.75 % 0.00508 gm Tincture of iodine, as described in Table 3
Th ymus Sicc.  8.75 % 0.02540 gm Dried thymus gland
P. Glycyrrhizae 17.50 % 0.05080 gm Powdered liquorice root
Dihydroxyphthalophene 2.75 % 0.00798 gm Phenolphthalein
Embryonic Subs. 8.75 %  0.02540 gm Literally, ‘embryonic substances’, which proba-
bly means ovary/embryo gland/mixture of 
glands/extract)
Trihydroxyoestrin 0.0105 % 0.0000305 gm or 
0.0305 mg
Estriol, a female sex hormone
Excipient to 100 % i.e. 25.50 %
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Discussion
As the founding director of Samona Ltd was a regis-
tered chemist and druggist and a community pharma-
cist of long standing in Newton-Stewart, Dumfries in 
Scotland, we believe that the various recipes given pre-
viously for the Samona brand tablets should be taken at 
face value. Th e listed non-gland ingredients would all 
have been readily obtainable. Unfortunately, we have 
no details of how the listed glandular substances ingre-
dients were made or from whom they were obtained. 
Given the time period (the late 1930s to early 1940s) 
and the recipe details, we believe that most were whole 
bovine glands which had been crushed and freeze dried. 
De-fatting may have taken place, and for any glandular 
extracts present a degree of solvent extraction may have 
been done.
Our historical recipe data currently far exceeds our 
chemical analysis data. Th e latter will be briefl y dis-
cussed later, and further work is in progress. We will 
now discuss the ingredients in the various recipes found 
for our tablets. A recipe is given on the labels of each of 
our bottles, where our No. 1 (for men) tablets were mar-
keted and made fi rst (spring 1938 to autumn 1941) and 
our No. 2 (for women) tablets came later (autumn 1941 
onward). 
As previously indicated, the recipes are fi rst men-
tioned in volume II of the twenty-second edition of 
Martindale’s Extra Pharmacopoeia, published in 1943. 
Its recipe for the No. 1 (for men) tablets was diff erent 
to that found on our bottle, but its recipe for the No. 2 
(for women) tablets was identical to that found on our 
bottle. Th us, overall we have the ingredients of three 
recipes to consider. Where possible and relevant, we 
have tried to provide both past (i.e. from the 1920s to 
the 1940s) and more recent (i.e. from the 1980s to the 
present) references when discussing the ingredients of 
our tablets.
Non-gland ingredients
We will fi rst discuss the non-gland ingredients of our 
three recipes. Overall there are fi ve such ingredients. 
Red cinchona bark and tincture of iodine are listed in 
all three recipes. Liquorice root is found in the recipes 
given on the labels of both our bottles. Phenolphthalein 
is only found on our bottle label of the No. 2 (for wom-
en) tablets, and the concentrated vitamin E is only 
found in the recipe for the No. 1 (for men) tablets in 
the 1943 Extra Pharmacopoeia. 
Cinchona bark, sometimes known as Peruvian or 
Jesuit bark (the latter reputedly arising from the people 
who fi rst discovered it in South America and brought 
it to Europe in the early 1630s) generally comes in three 
colours; red, yellow and grey-white. Red usually con-
tains the most alkaloids – specifi cally the biologically-
active quinine – and grey-white the least. Th e bark was 
powdered and ingested (often in wine) as a prophylactic 
against and then for the fever if bitten by a malaria-
carrying mosquito. It found use as a bitter tonic, and 
also as an astringent.16, 17 Th e compounds found in the 
bark include several alkaloids and alkaloid-related mol-
ecules, a bitter amorphous glucoside (quinovin), starch 
and calcium oxalate.18 
Liquorice is the usually peeled root of Glycyrrhiza 
glabra, an herbaceous perennial found in southern Eu-
rope and Asia. It has been, and still is, used as a demul-
cent, sweetener and as a mild expectorant. However, 
other past medicinal uses are now being re-investigated, 
including its use for the relief of rheumatic pain and its 
healing eff ect on ulcers; and a whole range of potential 
new bioactive/physiological eff ects have been suggested. 
Th e root has been found to contain many compounds, 
including fat, starch, various sugars (one of which is su-
crose), fl avonoids, phenolic compounds and what is 
considered to be its main biologically-active – and 
sweet-tasting– compound of glycyrrhizin (a triterpene 
glycoside).19, 20 It was, and still is, used to disguise the 
presence of unpleasant-tasting or bitter ingredients in a 
medicine, such as the cinchona bark in Dr Sappington’s 
Fever Pills.21
Tincture of iodine is a solution of iodine dissolved 
in alcohol, with a concentration range for the iodine of 
between 2 and 10 per cent.22 It was used (and still is in 
such things as emergency medical survival kits), as a 
water disinfectant and as an antiseptic for external use 
on wounds. It was also important in the treatment of 
thyroid gland disease (iodine defi ciency leading to goi-
tre).23, 24 
Phenolphthalein is a man-made mild laxative. It 
was widely used on adults and children from the begin-
ning of the twentieth century.25, 26 However, in 1999 it 
was deemed unsafe by the United States Food and 
Drug Administration (FDA) and its use was prohibited 
in the USA.27 
Vitamin E consists of a small group of structurally-
related molecules, where the most biological-active is 
alpha-tocopherol. Th e molecules can now be made in 
the laboratory, but were originally found in various nat-
ural food sources (such as wheatgerm, maize and pea-
nut oils). In the early 1940s vitamin E concentrate was 
available as small capsules of oil concentrate (often 
wheatgerm). If an adult is defi cient in vitamin E then 
ingesting some concentrate should remove/reduce such 
symptoms as lack of vitality, muscle weakness and de-
creased sexual interest. It is an anti-oxidant and is being 
investigated, and sometimes used, for a variety of ther-
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apeutic uses – such as for burns, scar tissue healing, 
treatment of skin ulcers and low fertility.28, 29 
Gland/Glandular Extract/Hormone ingredients
Organotherapy in its broadest sense is the use of an an-
imal part as a medicine for a human ailment. Various 
past civilisations used animal parts as medicines and 
the belief of ‘like cures like’ arose. Examples include: 
heart preparations for cardiac disease, toad’s skin for 
oedema, testis of donkeys and stags for impotence, and 
the potion Th eriac (originally for viper’s bites, but 
which later became a ‘cure-all’) contained various ex-
otic animal parts (including crushed vipers).30 
In the late nineteenth century organotherapy in-
creasingly focussed on the medicinal use of animal 
glands. Th ese were the whole glands (crushed and 
dried) or their extracts (where their quality and purity 
could vary greatly). Th ese extracts – especially from the 
sex glands – became vastly more well-known (and 
much more studied) after the extraordinary rejuvena-
tion claims of Charles-Edouard Brown-Sequard in 
1889 after his self-medication of ‘testicular extracts’. 
Although much ridiculed, his claims and publications 
continued until he died in 1894, and they started an 
avalanche of studies on all manner of extracts.31, 32, 33 
Th ere were some initial successes in the early 1890s. 
Th yroid extract, especially when subcutaneously inject-
ed, was used to successfully treat myxoedema (1891), 
and to a lesser extent adrenal extract gave vasopressor 
eff ects (1894). However, when pancreatic juices and ex-
tracts were tried between 1890 and 1892 for the treat-
ment of diabetes they were unsuccessful.34, 35, 36 Testing 
of extracts continued for about another three decades. 
In the fi rst decade of the twentieth century there was 
the beginnings of the new medical speciality of endo-
crinology – the study of ductless glands and their ‘in-
ternal secretions’. Th e latter were named hormones 
(from the Greek ‘I arouse or excite’) in 1905.37, 38 
Extracts of sex glands were studied and prescribed 
for their tonic or rejuvenation eff ects, in the United 
States, Great Britain and in Western Europe into the 
1920s and beyond. Some positive results were claimed39, 
40, 41 but overall the initial expectations – often wildly 
optimistic – were not realised. In 1922 the American 
biochemist Benjamin Harrow made the perceptive 
statement:
Th e achievements [of endocrine science], judged by 
rigid scientifi c standards, are no more than modest, 
but the possibilities are limitless. It is because of 
these vast possibilities that an imagination, not suf-
fi ciently tempered by self-criticism, is apt to enlarge 
a molehill into a mountain.42 
Extracts of the thymus and prostate glands
Two other glands should be mentioned concerning 
their medicinal eff ects and uses – the thymus and pros-
tate glands. Th e former is on the labels of both our bot-
tles as part of their recipes, and the latter is only on the 
label of our ‘No. 1 (for men)’ bottle.
Th e function(s) of the thymus gland was unclear for 
some time. Initially it was thought that its extract could 
contain a growth-accelerating factor, or that perhaps 
there was a possible link between it and the develop-
ment or not of the gonads or uterus. However, from the 
1930s such ideas became increasingly suspect. Eventu-
ally it was realised that the gland was prominent in cel-
lular immunity, and also involved in the adverse reac-
tions of graft rejection and allergies.43, 44 
Th e prostate gland is an ancillary (exocrine) male 
sex gland associated with the male reproductive system. 
In the late nineteenth century the prostate was per-
ceived as a ‘biological control centre’ and to be the ‘cen-
tre of the male sexual system’. It was thought that pros-
tate problems, such as enlargement and/or infl ammation, 
could lead to nervous conditions such as sexual neuras-
thenia. Th us, in the fi rst few decades of the twentieth 
century when glandular substances were increasingly 
available, a treatment involving medicines was regarded 
as better than a surgical operation.45 Prostate gland 
medicine was sometimes marketed as part of a mixture 
– such as a mixture of prostate and testis glands and 
brain tissue (marketed as Prostatin and also as Protestin, 
with added yohimbine hydrochloride or yohimbine re-
spectively).46 
Hormones were being isolated from the start of the 
twentieth century; but it was time consuming, diffi  cult 
and often very expensive. By the 1920s it was easier and 
not so expensive, and eventually they would be made 
directly in a laboratory by synthetic chemists.47 Th e re-
sults of using male sex hormones in human clinical 
studies can best be summarised by three statements 
from the late 1930s to the late 1940s. A 1939 report 
found no ‘signifi cant aphrodisiacal eff ect in the normal 
man’; a 1944 report found that ‘normal men experience 
little, if any, increase in sexual potency or in well-being 
by taking the male sex hormone’; and a 1949 report 
stated that for female patients ‘testosterone supplemen-
tation produced no increase in libido in post-menopau-
sal women with normal testosterone levels’.48 
Th e female sex hormone estriol is listed in the reci-
pe on the label of our bottle for the ‘No. 2 (for women)’ 
tablets. It was fi rst isolated and reported in 1929/30, 
was found to be a weak oestrogen, and was suggested 
initially for a whole range of (female) conditions.49, 50 It 
is currently regarded as a potentially safer hormone to 
use in hormone replacement therapy (HRT) for meno-
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pausal symptoms. However, further safety studies, es-
pecially with regard to breast cancer, are regarded as 
necessary.51 
Other glandular substances in the tablet recipes
Further consideration will now be given to the inter-
pretations of the various glandular substances given in 
the recipes for our tablets (excluding the hormone given 
in one recipe, which has already been mentioned); both 
on the labels of our two bottles, and in the 1943 Extra 
Pharmacopoeia. 
A) ‘No. 1 (for men)’ tablets: ‘Th ymus Sicc.’ is taken 
to be dried thymus gland; ‘Prostatine Sicc.’ is either 
dried prostate gland or possibly a mixture as mentioned 
above – prostate and testis glands plus brain tissue; and 
‘Didymin Sicc.’ is dried testicular extract52 – all from 
the label on our bottle. Th e interpretations of the two 
glandular substances mentioned in the 1943 Extra 
Pharmacopoeia recipe are largely speculation, as no de-
fi nitive information could be found – ‘Bitestin Stand-
ard’ is assumed to be some sort of standardised testis 
extract, and ‘Corp. Glandulae Compos.’ is assumed to 
be a mixture of glands.
B) ‘No. 2 (for women)’ tablets: ‘Th ymus Sicc’ is as 
above, and ‘Embryonic Subs.’ is assumed to be crushed 
and dried animal ovary gland – both on the label of our 
bottle and in the 1943 recipe.
Th e amount of each ingredient per tablet for our 
two samples (given previously) can be compared to the 
relevant dosages given in the 1941 Extra Pharmacopoe-
ia. No toxicity would be expected from taking three 
tablets a day (as recommended), as the total amount of 
each ingredient ingested would be signifi cantly less 
than the dosages given in the above Pharmacopoeia.53 
Th is assumes that the thymus gland dosage range given 
in the Pharmacopoeia can be applied to the other glan-
dular substances present in our tablets. 
Discussion of the analytical chemistry data
Th e results from the XRPD and QEMSCAN analyti-
cal techniques used by us have identifi ed the excipient 
in both our tablets as largely a sugar (sucrose), with 
smaller amounts of several inorganic compounds (such 
as talc, calcite and apatite). Th e only information we 
have, albeit limited and preliminary, on the non-excip-
ient organic compounds present in the ‘No. 1 (for men)’ 
tablets is from the MS analytical technique.
Th e molecules found by this last technique were 
two (fairly common, especially in fats and oils) fatty 
acids (stearic and palmitic), an unidentifi ed hydrocar-
bon and two sugar-containing molecules (assumed to 
be glycosides). All could be present in either the red cin-
chona bark or liquorice root of the non-glandular in-
gredients. Also, whilst no small molecule hormones 
(e.g. steroids) were found, the analysis was preliminary 
and further work is needed, especially to search for larg-
er molecules such as peptides/polypeptides and (small) 
proteins that perhaps are to be found in crushed and 
dried whole glands or their extracts. However, a degree 
of molecular decay (especially of these larger molecules) 
may have occurred since they were fi rst made (i.e. about 
eighty years ago). Th us, overall our identifi ed organic 
molecules could also have come from the glandular sub-
stances either originally present or their from decay 
products. It is hoped future (GC/LC-MS) results will 
shed more light on the composition of our tablets.
Conclusion
Overall, from the recipes on the labels of our two bot-
tles, dating from the late 1930s to the early 1940s, there 
are present in our tablets (from the non-glandular in-
gredients): a bitter tonic (cinchona), a sweetener/expec-
torant (liquorice), an antiseptic (tincture of iodine) and 
a mild laxative (phenolphthalein). Also present are glan-
dular substances – either whole glands or their extracts 
– from the prostate, testis, thymus and (probably) ova-
ry glands. Th ere is one hormone present in a very small 
amount: the female sex hormone estriol. 
Whilst the eff ects of the non-glandular ingredients 
were known, the eff ects from the various glandular sub-
stances (and the hormone) present were uncertain at 
this time. A tonic/stimulant eff ect could however be 
expected, especially if defi ciencies from disease and/or 
poor diet during the Second World War were present 
in the people ingesting our tablets. Today, few physi-
cians would prescribe organs or their extracts; however, 
they are available online or in some Chinese medicine 
shops. Hormones are prescribed, such as in HRT for 
menopausal symptoms. 
Whilst we cannot currently prove the presence of 
glandular substances in our tablets from our analytical 
data, we hope to be able to do so in the future. What 
we do have are detailed recipes from the reputable com-
munity pharmacist who founded the company.
Th us a mild tonic eff ect could be expected from tak-
ing our tablets. Combine this physiological eff ect with 
additional expectations from extensive advertising and 
from the positive information and anonymous testimo-
nials given on the bottle, box and leafl et. So the real 
could combine with the imagined/expected to give a 
larger, or even much larger, eff ect. 
But would the eff ect be aphrodisiacal? Th is would 
probably largely depend on user expectations. It was 
never, as far as we are aware, advertised as such explic-
itly, but the psychotherapeutic eff ects from suggestive 
advertising and from the words (on the labels of the 
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bottles) ‘Makes Life Anew’ should not be underesti-
mated. 
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A R T I C L E
Ichthyocolla: medicinal ‘fi sh glue’
Christopher J. Duffi  n
Abstract
Ichthyocolla is a collagen-rich medicinal simple, origi-
nally derived from many parts of the parent fi sh, but 
more commonly restricted to Acipenseriform swim 
bladders imported from Russia in early modern times. 
Used to treat headache, tetanus and leprosy in classical 
times, the medieval Arabic tradition saw it utilised 
against haemorrhoids. Th e colloidal nature of the pro-
cessed material was exploited in early modern medicine 
where it was used to treat haemorrhoids, leucorrhoea, 
diarrhoea, and dysentery. Remarkable for its adhesive 
properties, it was used topically to bind the separated 
lips of wounds together, to stabilise broken ribs, and in 
medicinal plasters.
Introduction
Th e creation of a systematic inventory of the contents 
of surviving late seventeenth and early eighteenth cen-
tury materia medica collections from the United King-
dom has provided an opportunity to examine the his-
tory of use of a wide range of medicinal simples.1 Initial 
results have been reported mostly for zoological and 
geological medical materials.2 Th e object of the present 
contribution is to consider the use to which ichthyo-
colla was put in the history of pharmacy.
Ichthyocolla is the name given to the swim bladder 
(often referred to as the ‘sound’ in older literature) of 
extant teleost fi shes. Essentially an internal gas-fi lled 
bag-like organ with collagen-rich walls, the swim blad-
der has been used historically for a variety of non-med-
ical purposes, including as a condom, as a source of 
protein in foods (particularly as maw in Chinese cui-
sine), to add lustre to silk,3 and to produce a water-re-
sistant animal glue.4 Soluble colloidal collagen can be 
produced by breaking the hydrogen bonds stabilising 
the triple helix structure of the original collagen mol-
ecule, usually by acid hydrolysis. Th e resulting molecule 
(the source of isinglass) is amphoteric (possesses both 
positive and negative charges) and, added as an emul-
sion to beer and wine, acts as a fi ning agent by fl occu-
lating spent yeast cells and other particles, thereby clar-
ifying the liquid. According to Hill (1751) in Georgian 
times it was ‘the most effi  cacious, as well the most safe 
and innocent of all the Ingredients they use for clearing 
their Wines’.5 Concerns over potential allergenicity in 
modern times have led to attempts to fi nd replacements 
for isinglass.6
order to spawn. Late maturing, it can grow up to 7 me-
tres in length, weigh up to 1,500 kilograms, and live 
for over 100 years. Now critically endangered due to 
overfi shing and poaching, trade in Beluga Sturgeon is 
heavily restricted. Its primary occurrences are in the 
Caspian and Black Sea Basins.
In brief, the functions of the swim bladder are (1) 
to maintain neutral buoyancy; (2) to act as an adjust-
able fl oat thereby optimising swimming energetics at 
diff erent depths – by varying the bladder volume, the 
fi sh adjusts its overall specifi c gravity allowing it to sink 
or ascend the water column; (3) to act as a stabilising 
agent by maintaining a proper centre of gravity – the 
bladder is located in the dorsal midline above the gut, 
so that the centre of mass is below the centre of volume; 
(4) to provide a reservoir of stored oxygen for aerobic 
respiration; and (5) to act as a resonating chamber in 
order to produce or receive sound.
In the Sturgeon, the swim bladder is of the relative-
ly primitive physostomous type. Here, the bladder re-
tains a connection to the alimentary canal by means of 
the pneumatic duct; replenishment of the gases in the 
bladder is achieved by the animal swimming to the sur-
face and gulping air from the atmosphere. Excess gas 
can be voided from the bladder in the same way.
In 1751 Sir John Hill (1714-1775) explained the 
process by which ichthyocolla was harvested from the 
parent fi sh.  Having removed the fi ns close to the body, 
the ‘Bladder, Stomach and Intestines’ were removed, 
carefully washed, diced and then steeped in water for a 
24-hour period.  Th en the mixture was boiled until 
there was clear evidence of material going into solution, 
after which it was strained through fl annels and cooled. 
The lighter supernatants were then progressively 
Figure 1. Huso huso (Linnaeus, 1758) (Family Acipens-
eridae), the Beluga Sturgeon; complete fi sh in right lateral 
view. (Source: From Stephenson (1838) Medical Zoology 
and Mineralogy, Plate 21, fi g. 2)
Although applied in some contexts to a wide variety of 
bony fi shes, both freshwater and marine, in historical 
medicinal contexts ichthyocolla most commonly refers 
to the swim bladder of the Beluga Sturgeon, Huso huso 
(Linnaeus 1758) (Family Acipenseridae), sometimes re-
ferred to as the Isinglass Sturgeon (Figure 1). Th e source 
of beluga caviar (roe from the female), this fi sh is ana-
dromous, migrating from salt waters into freshwater in 
https://doi.org/10.24355/dbbs.084-202007300934-0
 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/4 117
skimmed off  the surface and removed, leaving a residue 
which ‘till by Trials they fi nd, that on letting a Spoon-
full of it cool it will harden to the Consistence of Glew’. 
Th is was then poured onto large wooden table surfaces 
and allowed to cool further until it could be cut and 
rolled up.
Hill records Russia as being the greatest exporter of 
the fi nal product, with the Volga and the Danube be-
ing the rivers most heavily fi shed for the Sturgeon.7 
Caspar Neumann (1683-1737), at various times apoth-
ecary in Poland, Berlin, England as well as travelling 
apothecary to Frederick I of Prussia, records that ‘Many 
waggon loads of this fi sh are brought to Vienna, in au-
tumn, every Friday afternoon, and sold next morning 
by the pound’.8
the individual leaves to stick together and dry out (Fig-
ure 2).10
John Jacob Berlu (dates unknown, seventeenth cen-
tury), a London drug and spice merchant, was well 
placed to describe in his Treasury of Drugs Unlock’ d the 
range of imports he received as ichthyocolla. He states 
that:
Th e best sort is the Patriarch sort, four square, very 
thin and white, almost transparent, the large Horse-
shooe sort in thin Rings, and clear, called the Czars 
sort, is the next; that which is yellow and brown 
within, a thick sort, is inferiour; that in square Books 
or Cakes, the worst of all.11
Figure 2. Prepared ichthyocolla, from Jackson (1773, pl. 1). 1, short staple isinglass; 2, saw knife; 3, Long staple isinglass; 
4, Book isinglass; 5, whole swim-bladder. (Source: By kind permission of the Royal Society)
Slightly later, Humphrey Jackson (1717-1801), who was 
apprenticed to an apothecary and surgeon in Stockton-
on-Tees and then moved to London to work as a chem-
ist,9 gave a more detailed account of the production of 
ichthyocolla. He records the extraction of the air-blad-
der ‘while sweet and fresh’, the removal of the sur-
rounding membranes, and the organ being air-dried 
before being rolled up. Th e whole structure was then 
folded roughly into a heart shape by judicious use of 
wooden pegs (Figure 2), and dried more fully in the air. 
Alternatively, the material could be folded into book-
like leaves, called cakes, which were then heated in a 
metal pan with a small amount of water in order to get 
It is clear that numerous substitutes for Sturgeon ich-
thyocolla, which was esteemed the best available, were 
easily obtained by the last quarter of the nineteenth 
century and particularly popular for brewing purposes. 
Th ese included products from India, China and Bra-
zil.12
Pharmaceutical uses
Th e earliest reference to ichthyocolla of which I am 
aware is that of the Roman naturalist, philosopher, au-
thor and military man, Pliny the Elder (AD 23-79). In 
his Naturalis Historia (Natural History), written around 
AD 76, he writes (Book XXXII, Cap. 24):
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‘Ichthyocolla’ is the name given to a fi sh with a glu-
tinous skin; the glue made from which is also known 
by the same name, and is highly useful for the re-
moval of epinyctis. Some persons, however, assert 
that it is from the belly of the fi sh, and not the skin 
– as in the case of bull glue – that the ichthyocolla 
is prepared. Th at of Pontus is highly esteemed: it is 
white, free from veins or scales, and dissolves with 
the greatest rapidity. Th e proper way of using it, is 
to cut it into small pieces, and then to leave it to soak 
in water or vinegar a night and a day, after which it 
should be pounded with sea-shore pebbles, to make 
it melt the more easily. It is generally asserted that 
this substance is good for pains in the head and for 
tetanus.13
According to Celsus (as described in the seven-volume 
medical compendium of the seventh century Byzantine 
Greek physician, Paulus Aegineta) Pliny commends it 
for the treatment of epinyctis – an archaism describing 
night-blains or bean-sized, painful, infl amed pustules 
that arise in the skin overnight – and also sores (also 
known as syces) on the eyelids.14
Pedanius Dioscorides (circa 40-90 AD), a near-con-
temporary of Pliny, refers to ichthyocolla in his De Ma-
teria Medica (Book III, Cap. 88). He repeats the asser-
tion that material from Pontus is of superior quality (as, 
supposedly, does Galen15) and commends it as a com-
ponent in head salves, facial lotions, and as a medica-
ment in the treatment of leprosy.16
Th ere seem to be few references to the use of ich-
thyocolla in the medieval Arabic tradition.  Th e Persian 
polymath, Avicenna (Ibn Sīnā; circa 980-1037), is be-
lieved to have completed his encyclopaedic medical vol-
ume entitled al-Qānūn f ī al-Ṭibb or Th e Canon of Med-
icine, constructed in fi ve books, in 1025. Highly 
acclaimed, it became a standard medical text in both 
medieval Europe and the Islamic world, and was used 
in western universities right through to the eighteenth 
century.17 Avicenna recommended ‘fi sh glue’ both in 
the treatment of haemorrhoids and, added to soups, in 
order to prevent the coughing up of blood (haemopti-
sis).18
Th e increasing importance and availability of stur-
geon ichthyocolla in early modern Europe is almost 
certainly a direct consequence of the opening of trade 
with Russia during the mid-sixteenth century. Ambi-
tions to fi nd a North East Passage to China led a series 
of adventurers to Russia, and meetings with the Tsar, 
Ivan IV Vasilyevich (Ivan the Terrible; 1530-1584).19 
Th e Muscovy Company, established in 1553 as a direct 
consequence of these meetings, monopolised trade be-
tween England and the Grand Duchy of Moscow for 
around the next 150 years. Certainly, references to the 
medicinal use of ichthyocolla, although still relatively 
sparse in comparison to those for other simples, increase 
in number through this period. Gideon Harvey 
(c.1640- c.1700) records that the price per pound in 
1678 was 5 shillings and 4 pence.20 By the late eigh-
teenth century, Charles Alston (1683-1760) was able to 
report that its use had declined considerably.21
Figure 3. Ichthyocolla from Drawer 23 of William He-
berden’s Materia Medica cabinet (early eighteenth century), 
St John’s College, Cambridge.  (Source: Reproduced by kind 
permission of the Master and Fellows of St John’s College)
Remains of contemporary apothecarial ichthyocolla 
survive in a number of early eighteenth century materia 
medica cabinets.  A well-preserved specimen is located 
in Drawer 23 of the teaching cabinet kept by William 
Heberden (1710-1801) whilst at St John’s College, 
Cambridge, for example (Figure 3). Further specimens 
are present in the Vigani Cabinet at Queen’s College, 
Cambridge,22 the Oglander Cabinet constructed by the 
apothecary Joseph Clutton in 1729 and held by Th e 
Museum for the History of Science in Oxford,23 and 
the so-called Corbyn Cabinet held by the Museum of 
the Royal Pharmaceutical Society in London.24
In an echo of Avicenna’s advice concerning the 
treatment of haemorrhoids, John Banister (1540-1610) 
recommended that ichthyocolla be employed in an em-
plaster (a sticky paste or salve applied directly onto the 
skin), together with Terra sigillata, Sanguis draconis, 
spider silk (Tela aranaea), Mastic, Th uris (resin from 
the Norway Spruce and other conifers), ‘pilo. Leporis’ 
(rabbit hair?), ‘Balaustiorum’ (Pomegranate), and ma-
rine shells.25 Banister recommended that any dried 
haemorrhoids be fi rst lanced or opened up by means of 
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horse leeches (Haemopis sanguisuga), before applying 
the salve.
Robert Boyle (1627-1691) suggests that ichthyocol-
la is a ‘powerful medicine’ in the treatment of ‘White 
Fluors’ (and similar ‘distempers’) – Fluor albus or leu-
corrhoea, a viscous white vaginal discharge accompa-
nying infl ammation of the vaginal mucosa and symp-
tomatic of a range of causes including oestrogen 
imbalance, vaginal infections and the presence of vagi-
nal trichomonad parasites. Boyle’s advice is to:
Take a Pottle of Ale, and shred into it two Ounces 
of white  Ichthyocolla (Isinglass) and in a loosely 
stopt Vessel, let the Liquor simper till about half is 
wasted; strain the rest, and give of it two or three 
Ounces at a time once or twice a day, as need shall 
require.26
Robert Lovell (c. 1630-1690) reports from Pliny that 
ichthyocolla ‘helpeth night Wheales’, and also suggests 
that, taken in a draught, ‘it helps the Lethargy’.  He also 
notes that, as an adhesive, it ‘serves to glew instruments 
withall’.27
As is often the case with medicinal simples in early 
modern texts written in English, William Salmon 
(1644-1713) provides the most extensive reference to 
the use of ichthyocolla. In respect of closing wounds by 
laqueation or ‘dry stitching’ techniques (where the two 
lips of the wound are pulled and held together), Salmon 
notes that ichthyocolla is an eff ective gluing agent. He 
indicates that the ichthyocolla should be dissolved in 
vinegar and then boiled to a glue-like consistency.
As indicated above, this means of processing would 
result in a colloidal, soluble collagen product. Once 
painted onto a binding cloth and laid over the wound, 
the preparation was ‘tenacious and strong, and will not 
be dissolved by the Humidities of the Wound’.28  For 
the same purpose, he also commends a paste made of 
ichthyocolla, wheat fl our, egg white, bird lime, traga-
canth, and powdered frankincense mixed together with 
Rose water. Many of these ingredients show similar col-
loidal and binding properties to that of the ichthyocol-
la; tragacanth, for example, is a gum obtained from the 
sap of Astragalus spp., a leguminous plant from the 
Middle East. Th e gum is harvested as fl akes and ribbon-
like extrusions from the root of the plant (Figure 4).29
One of the main components of the sap is tragacan-
thin, a mucilaginous colloid which is highly soluble in 
water. Th is, together with the closely associated amy-
lose, bassorin, a much less water-soluble but gel-forming 
carbohydrate, results in an eff ective binding agent 
which has a long history of use both topically (in burn 
treatments, for example) and internally. Salmon recom-
mends the same receipt for the treatment of broken ribs; 
the emplaster would have been painted onto strong lin-
en, laid over the position of the break and allowed to 
harden. In addition to protecting the area, the applica-
tion could be ripped off  the surface of the chest ‘sud-
denly with great violence’ in the hope of moving the 
broken ends of the ribs to a position where less pain was 
experienced, and the danger to the lungs from lacera-
tion by the broken ends of the ribs was reduced.30
Th e colloidal nature of ichthyocolla was also ex-
ploited in other ways. Its ability for the uptake of water 
to form a hydrogel led to it being appreciated both as a 
fi ller and as a drying agent (exsiccative).31 Applications 
derived from this included its use as ‘ischureticks’ – 
means of thickening the blood. William Salmon sug-
gests two ichthyocolla-containing receipts for this pur-
pose. One involved mixing the fi sh glue with fi nely 
powdered Comfrey root and sugar, while the other used 
Gum Tragacanth and Syrup of Lettuce, prescribing 
‘two Doses to be given Morning and Night in Milk’.32
As late as the nineteenth century it was still occa-
sionally being used in cases of lung and bowel com-
plaints, and was noted as being ‘peculiarly adapted to 
cases of chronic diarrhoea and dysentery in children’.33 
It was also seen as an emollient for softening the skin, 
and a demulcent (for reducing irritation and infl amma-
tion).34
Figure 4. Th e plant yielding Gum Tragacanth.  Note the 
fl akes of gum being exuded from the root surfaces. (Source: 
From Pomet, 1737, pl. 58: Note 29)
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Th e isinglass produced from ichthyocolla was also 
used to produce a high quality gelatin which was often 
mixed with wine and given to the sick and convales-
cents as a restorative.35 In addition, the adhesive prop-
erties of the material were exploited in the production 
of a sticking plaster for covering superfi cial wounds and 
known as court plaster.  Th e plasters consisted of silk, 
sarcenet or taff eta, coated on one side with an adhesive 
mixture of isinglass and glycerine. Th e name derives 
from their use in the eighteenth century by ladies at 
court for beauty spots. A fi nishing coat of either Tinc-
ture of Balsam of Peru (alcoholic solution of the resin 
from the Central and South American tree, Myroxylon 
balsamum), or Tincture of Benzoin (a solution of bal-
samic benzoin resin, obtained from the bark of Styrax 
spp., and dissolved in ethanol) was applied to give the 
plaster an agreeable odour, with the added benefi t of 
their styptic and antiseptic properties.36
According to fashionable trends, the plasters could 
be black, or fl esh-coloured by adding a few drops of 
Sanguis draconis, a red resin obtained from a variety of 
Mediterranean plants including the palm, Daemonorops 
draco. In an early nineteenth century eff ort to make 
these plasters waterproof, they might be impregnated 
with India Rubber dissolved in naphtha.37 Th is was a 
preferable alternative to the other commonly available 
plaster at the time – diachylon plaster, most varieties of 
which relied on litharge of gold (a mixture of litharge 
or lead (II) oxide, PbO, and red lead, Pb3O4) and a va-
riety of plant-based oils and adhesives.
Author’s Addresses: Dr Christopher J. Duffi  n, Scien-
tifi c Associate, Department of Earth Science, Palaeon-
tology Section, Th e Natural History Museum, Crom-
well Road, London SW7 5BD, UK, and 146 Church 
Hill Road, Sutton, Surrey, SM3 8NF, England.
Email: cduffi  n@blueyonder.co.uk
Endnotes and References
1. Duffi  n, CJ. Some early Eighteenth Century geological 
Materia Medica.  In Duffi  n, CJ., Moody, RTJ. & Gardner-Th or-
pe, C.  (eds.) A History of Geology and Medicine. Geological So-
ciety of London Special Publication, 2013; 375: 209-233; Duf-
fi n, CJ. British Eighteenth Century Materia Medica Collections. 
In Polyakova, IA., Duffi  n, CJ., & Suvorova, TJ. (eds) (in press): 
Collection in the Space of Culture. Kaliningrad, Kaliningrad Re-
gional Amber Museum.
2. See, for example, Duffi  n, CJ. Fossils as drugs: pharma-
ceutical palaeontology. Ferrantia, 2008; 54: 1-83; Duffi  n, CJ. 
Lapis de Goa: the ‘Cordial Stone’. Pharmaceutical Historian. 
2010a; 40 (2): 22-32; Duffi  n, CJ. Lapis de Goa: the ‘Cordial 
Stone’: Part Two. Pharmaceutical Historian. 2010b; 40 (3): 42-
46; Duffi  n, CJ. Porcupine Stones. Pharmaceutical Historian. 
2013; 43 (1): 13-22; Duffi  n, CJ. Historical survey of the internal 
use of unprocessed amber. Acta medico-historica Adriatica. 2015; 
13 (1): 41-74; Duffi  n, CJ. ‘Fish’, fossils and fakes: medicinal uni-
corn horn. In Duffi  n, CJ., Gardner-Th orpe, C. & Moody, RTJ. 
(eds) Geology and Medicine: Historical Connections. Geological 
Society of London Special Publication. 2017a; 452: 211-259; 
Duffi  n, CJ. Medicinal Boar’s teeth. Acta Historiae Medicinae, 
Stomatologiae, Pharmaciae, Medicinae Veterinariae. 2017b; 36(1-
2): 20-34;  Duffi  n, CJ. Amber as a component of palaeontolog-
ical pharmacology. In Polyakova, I., Duffi  n, CJ. and Suvorova, 
TJ. (eds) Amber in the history of medicine: Proceedings of the In-
ternational Conference. Kaliningrad: Kaliningrad Regional Am-
ber Museum [dated 2016], 2018b: 95-132.
3. Jahr, GH. New Homoeopathic Pharmacopoeia and Posol-
ogy, or the Preparation of Homoeopathic medicines and the Admin-
istration of Doses. Philadelphia: J. Dobson, 1842: 253.
4. Huxley, J. Material of Early Contraceptive Sheaths. 
British Medical Journal, 9 March 1957: 581-582.
5. Hill, J. A history of the materia medica. Containing de-
scriptions of all the substances used in medicine, their origin, their 
characters when in perfection, the signs of their decay, their chymi-
cal analysis and an account of their virtues, and of the several prep-
arations from them now used in the shops. London:  T. Longman, 
C. Hitch and L. Hawes, 1751: 895.
6. Leiper, KA. and Miedl, M. Colloidal stability of Beer. 
In Bamforth, CW. (ed.): Beer: A Quality Perspective. Amsterdam: 
Academic Press, 2011: 111-162.
7. Hill, J. (Note 5), 1751: 895.
8. Lewis, W. 1773. Th e Chemical works of Caspar Neu-
mann, M.D. Volume 2. Second edition. London: Printed for J. 
& F. Rivington; T. Davies; W. Johnston; G. Keith; S. Crowder; 
T. Caslon; T. Longman; T. Becket; B. Law; E. & C. Dilly; G. 
Robinson; T. Cadell; and W. Goldsmith, 1773: 410.
9. Appleby, JH. Humphrey Jackson, FRS., 1717-1801: A 
Pioneering Chemist. Notes and Records of the Royal Society. 1986; 
40 (2): 147-168.
10. Jackson, H. An account of the discovery of the manner 
of making isinglass in Russia; with a particular description of its 
manufacture in England, from the produce of British fi sheries. 
In a letter from Humphrey Jackson, Esq., FRS to William Wat-
son, MD, FRS. Philosophical Transactions of the Royal Society. 
1773; 63: 1-15.
11. Berlu, JJ. Th e treasury of drugs unlock’ d, or, A full and 
true description of all sorts of drugs and chymical preparations sold 
by druggists whereby you may know the place of their growth and 
how to distinguish the good from the bad : very useful for all gentle-
men, merchants, druggists, doctors, apothecaries, chirurgeons, and 
their apprentices. As also for all Travellers, Seamen, Customhouse 
Offi  cers, and all others that either Traffi  ck in them, or make any use 
of them, or those that Import or deliver any of ‘em at the Waterside. 
Giving a true Account of all those that are Prohibited, and those 
that, whereby many needless Disputes and Suits may be prevented 
the whole work alphabetically digested with a compleat catalogue of 
all drugs, &c. London: Printed for John Harris at the Harrow 
against the Church in the Poultrey, and Th o· Howkins in 
George-Yard, in Lombard-stret, 1690: 60.
12. Anonymous. Ichthyocolla, Indian and Chinese. Year-book 
of Pharmacy comprising Abstracts of papers relating to Pharmacy, 
Materia Medica, Th erapeutics, & Chemistry contributed to British 
and foreign journals from July 1 1869 to June 30 1870 with the 
Proceedings of the British Pharmaceutical Conference at the Seventh 
Annual Meeting held at Liverpool September, 1870. 1870: 75-77.
13. Bostock, J. and Riley, HT. Th e Natural History. Pliny 
the Elder. London: Taylor and Francis, Red Lion Court, Fleet 
Street, 1855.
14. Adams, F. Paulus Aegineta. Translate from the Greek. 
Volume 2. London: Sydenham Society, 1846: 40.
https://doi.org/10.24355/dbbs.084-202007300934-0
 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/4 121
15. Galen. Spurii Galeno Ascripti libri qui variam artis 
medicae farraginem ex variis auctoribus excerptam continentes 
optimo, quo fi eri fortuity, ordini sunt dispositi, & in unum cor-
pus redacti. Venetijs: apud Iuntas, 1586: 90.
16. Beck, LY. Pedanius Dioscorides of Anazarbus.  De Mate-
ria Medica. Altertumswissenschaftliche Texte und Studien, 38. 
Hildesheim: Olms-Weidmann, 2011: 224.
17. McGinnis, J. Avicenna. Oxford: Oxford University 
Press, 2010: 227.
18. Bakhtiar, L. Th e Canon of Medicine (al-Qānūn f ī al-
Ṭibb) (Th e Law of Natural Healing). Volume 2. Natural Pharma-
ceuticals. Chicago: Great Books of the Islamic World, Inc., 2012: 
460; Bakhtiar, L. Th e Canon of Medicine (al-Qānūn f ī al-Ṭibb) 
(Th e Law of Natural Healing). Volume 3. Special Pathologies. Chi-
cago: Great Books of the Islamic World, Inc., 2015: 1048.
19. Alford, S. London’s Triumph. Merchant Adventurers and 
the Tudor City. St Ives: Allen Lane, 2017.
20. Harvey, G. Th e family-physician, and the house-apothe-
cary containing I. Medicines against all such diseases people usually 
advise with apothecaries to be cured of, II. Instructions, whereby to 
prepare at your own houses all kinds of necessary medicines that are 
prepared by apothecaries, or prescribed by physicians, III. Th e exact 
prices of all drugs, herbs, seeds, simple and compound medicines, as 
they are sold at the druggists, or may be sold by the apothecaries, IV. 
Th at it’s plainly made to appear, that in preparing medicines thus 
at your own houses, that it’s not onely a far safer way, but you shall 
also save nineteen shillings in twenty, comparing it with the extrav-
agant rates of many apothecaries. 2nd edition. London: Printed for 
M. R., 1678: 127.
21. Alston, C. Lectures on the Materia Medica: Containing 
Th e Natural History of Drugs, their Virtues and Doses: also Direc-
tion for the Study of the Materia Medica; and An Appendix on the 
Method of Prescribing, Volume 2. London: Edward & Charles 
Dilley, 1770: 530.
22. Drawer R, Cell 5. Wagner, L. Fine Art Materials in Vi-
gani’s Cabinet (1704), of Queen’s College, Cambridge. Unpub-
lished Ph.D. thesis, University of Erlangen, 2007.
23. Drawer labelled ‘Partes. Anim.’ Oglander Cabinet, 
1729. Oxford: Museum for the History of Science.
24. Drawers 16 and 17. Corbyn Cabinet, 1760. London: 
Museum of the Royal Pharmaceutical Society of Great Britain.
25. Banister, J. A needefull, new, and necessarie treatise of 
chyrurgerie briefl y comprehending the generall and particuler cura-
tion of vlcers, drawen foorth of sundrie worthy wryters, but espe-
cially of Antonius Calmeteus Vergesatus, and Ioannes Tagaltius, by 
Iohn Banister Gent. practiser in Physicke and Chyrurgerie. Here-
unto is anexed certaine experiments of mine ovvne inuention, true-
ly tried, and daily of me practised. London: Th omas Marshe, 1575: 
65.
26. Boyle, R. Medicinal experiments, or, A collection of choice 
and safe remedies for the most part simple and easily prepared, use-
ful in families, and very serviceable to country people by R. Boyle ; 
to which is annexed a catalogue of his theological and philosophical 
books and tracts. 2nd edition. London: Printed for Sam. Smith, 
at the Prince’s Arms in St. Paul’s Churchyard, 1693: 185.
27. Lovell, R. Panzooryktologia. Sive Panzoologicomineralo-
gia. Or A compleat history of animals and minerals, containing the 
summe of all authors, both ancient and modern, Galenicall and 
chymicall, touching animals, viz. beasts, birds, fi shes, serpents, in-
sects, and man, as to their place, meat, name, temperature, vertues, 
use in meat and medicine, description, kinds, generation, sympathie, 
antipathie, diseases, cures, hurts, and remedies &c. With the anat-
omy of man, his diseases, with their defi nitions, causes, signes, cures, 
remedies: and use of the London dispensatory, with the doses and 
formes of all kinds of remedies: as also a history of minerals, viz. 
earths, mettals, semimettals, their naturall and artifi ciall excre-
ments, salts, sulphurs, and stones, with their place, matter, names, 
kinds, temperature, vertues, use, choice, dose, danger, and antidotes. 
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B O O K  R E V I E W
Th e Pharmacopoea Londinensis of 7th 
May 1618 from the London College of 
Physicians, in facsimile
With an Epilogue on its origins by Henry Oakeley 
FRCP
London: Royal College of Physicians, 2018. Pp. 184 + xvi. 
Hardback, price £xx.00. ISBN 978-1-86016-749-2. 
Available from https://shop.rcplondon.ac.uk.
Th e epilogue by Henry Oakeley begins by setting 
the scene, describing the position of the College and the 
events that led up to the book’s publication, although 
some of his statements perhaps need to be treated with 
a little caution. He indicates, for example, that the phar-
macopoeia was the result of ‘physicians and apothecaries 
working closely together’. Yet in her history of the Soci-
ety of Apothecaries Penny Hunting tells us that the ‘six 
apothecaries were consulted about the publication at the 
eleventh hour’, only being called upon in February 1618, 
the pharmacopoeia having been on the point of comple-
tion the previous September. And despite the assiduous 
daily attendance of six of them, one of their number – 
John Parkinson – claimed that the physicians ‘did not 
take the advice proff ered by the Apothecaries.’ 
Oakeley helpfully provides a comprehensive over-
view of earlier pharmacopoeias, noting that they pro-
vided the inspiration for the production of the London 
book in 1618. But he also gives the current reader a walk 
through its antecedents, starting with Sumerian records 
in the 4th millennium BC, continuing with published 
textbooks from Th eophrastus in the third century BC, 
and ending with the immediate precursors of the 1618 
publication. Th is section comments briefl y on the pub-
lications, their authors and their approaches, and also 
includes details of whether there are references within 
the Pharmacopoea Londinensis to these earlier works. As 
a brief guide to the broad history of pharmacopoeias, it 
works well and provides very useful context for the 1618 
publication. Th e references giving full details of the pre-
cursor publications are also very helpful for researchers 
in this area. 
Th e epilogue concludes with a detailed analysis of the 
Pharmacopoeia Londinensis: its format and its inspiration; 
its contents including an interesting short discussion of 
the paucity of global origins of many of the ingredients; 
and the next stage in the story, the withdrawal of this 
fi rst edition to be replaced by a new, corrected and en-
larged version in December 1618. Only twelve copies of 
the May 1618 edition are known to exist, and so this 
high-quality facsimile of one of the survivors seems a 
very fi tting way to mark its 400th anniversary. 
Th e book will be of interest to pharmacy and med-
ical historians, those interested in medicines and ingre-
dients, those interested in the transmission of learned 
knowledge and its control, and those interested in the 
relationship between physicians and apothecaries, 
alongside rare books enthusiasts. Not least, it makes a 
handsome addition to a researcher’s bookshelves.
Reviewer’s address: Briony Hudson, Th e Coppins, New 
Road, Princes Risborough, Bucks, HP27 0LA, UK. 
Email: brionyhudson@hotmail.com
Reviewed by Briony Hudson 
Th e Pharmacopoea [sic] Londinensis was fi rst published 
by the (then) London College of Physicians on 7 May 
1618. To mark its 400th anniversary, the Royal College 
of Physicians (RCP) has published a facsimile of an 
original fi rst edition held in its library, with the inclu-
sion of an epilogue by Dr Henry Oakeley setting it in 
context.
As a facsimile, it is extremely satisfying. Th e deci-
sion was taken to reproduce the cover as well as the con-
tents so that – unwrapping it from its parcel – I was 
initially duped by its apparent age. Th e facsimile dupli-
cates the original book warts and all, so that the much 
later RCP library bookplate with its pencil shelf-marks, 
the scratchy handwritten note opposite the title page 
stating that it is the fi rst edition, and the stains and in-
considerately-placed stamp on the illustrated title page 
itself, are all faithfully reproduced. Of course, the con-
tents are all in their original Latin apart from the Eng-
lish royal proclamation, which was included by the 
compilers in 1618 to provide justifi cation for the pub-
lication. Handwritten annotations throughout give a 
sense of the book in use, with underlining, translated 
words and additions made by past readers, not to men-
tion stained pages. 
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Pharmacopoeia Londinensis 1618 
and its descendants
By Claire J Fowler
London: Royal College of Physicians, 2018. Pp. 140 + 
viii. Softback, price £15.00. ISBN 978-1-86016-714-0. 
Chapter 3 explains why the Pharmacopoeia Londin-
ensis 1618 was written, the physicians seeing it as a 
means of curbing the competition that apothecaries 
presented to their medical practice.  
Fowler suggests that a mention in the College min-
utes in 1614 to the preparation of the pharmacopoeia 
was a reaction to the expected establishment of an in-
dependent Society of Apothecaries. Chapter 4 explores 
the reasons why two version of the Pharmacopoeia 
Londinensis were published, one in May 1618 and a sec-
ond in December 1618.
Chapter 5 is devoted to the life, work and publica-
tions of Nicholas Culpeper, and to his translations of 
the Pharmacopoeia Londinensis. Finally, Chapter 6 de-
scribes the past and present gardens of the Royal Col-
lege of Physicians of London, including a garden map 
and a detailed description of the Pharmacopoeia Lond-
inensis beds, including a complete list of their contents. 
Fowler has clearly immersed herself deeply in Jaco-
bean history (the period covering the reign of King 
James VI of Scotland, 1567-1625, who was also King 
James I of England from 1603) and her scholarship is 
impressive. Of particular note are her novel hypotheses, 
based on meticulous and original research. Firstly, she 
off ers persuasive new evidence about a possible expla-
nation for the great diff erences between the May and 
December 1618 versions of the fi rst edition of the Phar-
macopoeia Londinensis. She suggests that it was Dr Th e-
odore de Mayerne who gave his copy of the text to the 
printer, resulting in the fi rst version. She discovered in 
Mayerne’s papers a handwritten page headed Pharma-
copoea [without an i, as in the printed version] Londin-
ensis sectiones listing the sections exactly as they appear 
in the May version.
Secondly, whilst conceding a lack of documentary 
evidence to support it, she suggests that King James was 
greatly encouraged by the success of his mediations be-
tween feuding ecclesiastical factions which resulted in 
the new translation of the Bible, and that working to-
gether on the Pharmacopoeia Londinensis might smooth 
the troubled relationship between the physicians and 
apothecaries. Although cooperation between the two 
groups is highlighted in the royal proclamation, this 
hypothesis is less convincing, given evidence elsewhere 
that the advice of the apothecaries was only sought at 
the last minute, and that even the advice off ered was 
ignored by the physicians. 
Th ere are other areas where assertions made need to 
be treated with care. An important consequence of the 
publication of the Pharmacopoeia Londinensis is claimed 
to be ‘its eventual evolution into the British Pharmaco-
poeia’. Th is is a little misleading. Following publication 
of the fi rst edition of the Edinburgh Pharmacopoeia in 
Reviewed by Stuart Anderson 
Th e fi rst edition of the London Pharmacopoeia ap-
peared in 1618, so it is no surprise that following its 
400th anniversary several publications marking the 
event have appeared. Th e fi rst edition has been subject 
to considerable scrutiny over the years by pharmaceuti-
cal historians, most notably George Urdang, who in 
1944 published an 80-page analysis alongside a repro-
duction of the pharmacopoeia itself. We might wonder 
therefore whether there is still anything new to say 
about it. 
In this book Claire Fowler, emeritus professor of 
uroneurology at the Institute of Neurology in London, 
describes the origins of the Pharmacopoeia Londinensis 
within the College of Physicians, the individuals in-
volved in its production, and some of its legacies. Th e 
book is divided into six chapters. Chapter 1 describes 
the origins of the College of Physicians and provides 
brief biographies of the fellows who were involved in 
writing the pharmacopoeia. Chapter 2 examines the 
origins and work of apothecaries, their role in the Gro-
cers Company, and the place of the physicians.
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1699 and the Dublin Pharmacopoeia in 1807, the RCP 
issued a new edition of the Pharmacopoeia Londinensis 
in 1809 which incorporated items from both the Edin-
burgh and Dublin ones. Th e RCP held discussions in 
the 1830s with the Edinburgh and Dublin Colleges 
with a view to creating a national pharmacopoeia, but 
the attempt failed, and a fi nal edition (the tenth) of the 
Pharmacopoeia Londinensis was published in 1851.
Progress towards a national pharmacopoeia was 
only made following passage of the Medical Act in 
1858, which established a General Medical Council for 
the United Kingdom (which included Ireland) and 
tasked it with publishing a book to be called the British 
Pharmacopoeia. When the fi rst edition of the British 
Pharmacopoeia was published in 1864 the RCP was dis-
missive; the president, Sir Th omas Watson, denounced 
the book as being a ‘dangerous one’ and that it should 
not be used. Th is was hardly a smooth evolution from 
Pharmacopoeia Londinensis to British Pharmacopoeia.  
Th ere are other places where pharmaceutical histo-
rians might have misgivings about some of the state-
ments made. No formal defi nition of a pharmacopoeia 
is given, and publications are variously described as an-
tidotoria, dispensatories, etc. Th is is not helped by the 
occasional use of ‘dispensary’ where ‘dispensatory’ is 
meant. 
Likewise, historians of pharmaceutical regulation 
may be surprised to learn that ‘the evolution of the law 
and regulation of medicines…can be traced back to the 
Pharmacopoeia Londinensis and the related publications 
from the sister colleges in Dublin, Edinburgh and Glas-
gow’. In fact, the history of drug regulation dates from 
a much earlier period, and in Britain encompasses the 
role of ‘garblers’ in the 1390s and the fi rst ‘poison law’ 
in Scotland in 1480. And the Royal College of Physi-
cians and Surgeons of Glasgow never produced a phar-
macopoeia. 
Th e issue of where the pharmacopoeia would be 
used also requires clarifi cation. Fowler suggests that it 
was James I who decided that it should be used ‘within 
this Realme of England and dominions thereof ’ rather 
than just London. In fact, it was through an Act of Par-
liament in 1523 that the remit of the London College 
was extended to the whole of England, and the same 
would have applied to the pharmacopoeia on its publi-
cation in 1618. 
Th e reference in the royal proclamation that it was 
made ‘in the sixteenth yeere of Our Reigne of England, 
France, and Ireland, and Scotland the one and fi ftieth’ 
is not the same as ‘within this Realme of England and 
dominions thereof.’ Th is was royal embellishment; 
James I styled himself ‘King of Great Britain and Ire-
land’ as well as ‘King of France,’ despite the fact that 
he had no authority whatever in France. Scotland and 
England were separate sovereign states, with their own 
parliaments and laws. Th e remit of the Pharmacopoeia 
Londinensis never extended beyond England and 
Wales. 
Likewise, the part played by the Pharmacopoeia 
Londinensis in the relationship between the diff erent 
groups is a little confused in places. Th e back cover tells 
us that it ‘was used in the struggles that marked the 
separation of two professions – the physicians and the 
apothecaries’. Yet they were already fully separated well 
before the apothecaries broke away from the Grocers 
Company in 1617 to form the Society of Apothecaries. 
Rather, as the author points out, the College took the 
view that it was separation of the apothecaries from the 
grocers that provided an opportunity to make the for-
mer subservient to the physicians, and that the phar-
macopoeia provided a means of doing so.
Yet despite these niggles the book has much to com-
mend it. It is on the whole an informative and enter-
taining read. Well over a third of the contents is devot-
ed to Culpeper and the RCP gardens. Th e book is 
clearly referenced, although an index would have been 
helpful. But those looking for brief and easily readable 
introductions to these subjects will fi nd much to inter-
est them here.
Reviewer’s address: Stuart Anderson, Centre for His-
tory in Public Health, London School of Hygiene & 
Tropical Medicine, London WC1E 7HT, UK. Email: 
stuart.anderson@lshtm.ac.uk.  
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Coca Wine: Angelo Mariani’s Miraculous 
Elixir and the Birth of Modern 
Advertising
By Aymon De Lestrange
Rochester, Vermont, US: Park Street Press, 2018. Pp. 
x+246. Paperback, price $40.00. ISBN 978-1-620-
55784-6. Ebook, ISBN 978-1-62055-783-3.
Vin Mariani became very popular in many coun-
tries, particularly France and the United States, and was 
claimed to be the most prescribed medicine. Th e story 
is told how the American President Ulysses S. Grant 
suff ered from terminal throat cancer, but wanted to 
write his memoirs for the family.  He was prescribed 
Vin Mariani, which relieved his pain and nourished 
him when he could no longer eat.  He fi nished his mem-
oirs a few days before he died.
Chapter 5 turns to advertising. Mariani was able to 
persuade famous artists like Mucha and Vallet to design 
posters for him. So many famous people gave testimo-
nials to his wine that he published 905 of them in al-
bums. Chapter 6 features Mariani’s hospitality, which 
included lavish banquets laid on for many of these fa-
mous people who became his close friends.
It is not surprising that such a successful product 
had its imitators. Chapter 7 lists other coca wines that 
were marketed in many countries, and the people who 
developed them. Th ese included Charles Pemberton of 
the United States who made Pemberton’s French Wine 
Coca, which had added kola nut and damiana. But in 
America in 1885 a law was passed prohibiting the sale 
of alcohol. Pemberton removed the wine and damiana, 
added sugar syrup, citric acid and soda, and renamed 
his product Coca-Cola. England had its own coca 
wines, including Hall’s Coca Wine, Armbrecht’s Coca 
Wine, and Buckfast Tonic Wine – a de-cocainized ver-
sion of which is still on sale today.
By the end of the nineteenth century there had been 
a great increase in cocaine addiction, and in America, laws 
were introduced to control sales. Chapter 8 deals with the 
change in regulation of cocaine from prescription to pro-
hibition. Many preparations relied on added cocaine. 
Mariani maintained that his product contained no added 
cocaine, but only the infused leaves. He later used de-co-
cainized leaves. Mariani died in 1914. His son continued 
the business, and Vin Mariani was on sale until 1961.
At the end of the book is a chronology of coca, co-
pious endnotes on the chapters, a bibliography of pub-
lished works by and about Angelo Mariani, and a com-
prehensive index.
Th is is a very informative and easy to read book. It 
provides a history of coca, cocaine, product advertising 
and the man who produced what was to become, in its 
time, the world’s most famous medicine. Th e lavish il-
lustrations are of a very high quality, and there is hard-
ly a page that does not possess one. Th is is a book for 
all those with an interest in the history of pharmacy.
Author’s address: Peter G. Homan, 3 Th e Ridings, Ep-
som, KT18 5JQ, UK.
Email: p.g.homan2@btinternet.com.
Reviewed by Peter Homan 
Th is decorative and informative paperback tells the sto-
ry of Angelo Mariani, a French pharmacist and entre-
preneur, who produced a tonic wine that he labelled Vin 
Mariani. It contained coca and Bordeaux wine, and 
became famous throughout the world. Th e book con-
tains eight chapters, plus acknowledgements, added in-
formation and a comprehensive index.
Chapter 1 presents a brief history of coca, an ever-
green shrub that grows on the slopes of the Andes.  Th e 
leaves have been chewed from at least 6050 BCE. It 
played an important role in medicine, religion, leisure 
time and work. Th e author quotes Conquistador Pedro 
Cieza de Leon, who in 1553 wrote that ‘coca is one 
thing that the Indians are never without in their 
mouths; from morning until they lie down to sleep, 
they never take it out’.  
Chapter 2 tells of the early life of Angelo Mariani 
– born Ange-Francois Mariani – on 29 December 1875, 
and the formulation of his coca wine. Chapter 3 de-
scribes his factory and the diff erent products that he 
produced there based on coca, whilst chapter 4 explores 
‘Th e Medicinal Virtues of Vin Mariana’ which includ-
ed relief from pain, added nutrition, general tonic ef-
fects, and a cure for a morphine habit. 
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Old English Medical Remedies: 
Mandrake, Wormwood and Raven’s Eye
By Sinéad Spearing
Barnsley, UK: Pen & Sword, 2018. Pp xviii+172. Hard-
back, price £19.99. ISBN 1526711702.
After providing a very useful overview of its place 
in the rather limited range of available Old English 
medical texts, she considers potential candidates for au-
thorship of the volume, the unique elements of its struc-
ture, problems associated with its translation, and the 
contemporary intellectual environment of its composi-
tion. Taking the reader to the heart of the text – and 
sometimes arguing the fi ner points of etymology – the 
author speculates persuasively about the impact of pre-
vailing contemporary beliefs on prescribing practice. 
In so doing, she takes the reader into the unfamiliar 
territory of a world view that saw the activities of a 
range of supernatural beings – elves, dwarves, hags and 
nightwalkers – as being amongst the causes of certain 
diseases. Psychological theory, etymology, archaeology, 
classical and later historical texts, a broader view of 
herbal treatments, Christian syncretism, and a delight-
fully expansive and erudite understanding of the philo-
sophical underpinnings of a wide range of folk beliefs 
(some with echoes surviving to the present day), are all 
cleverly focused on elucidating the context and signifi -
cance of the recipes under consideration, and lead the 
reader down some interesting philosophical alleyways.
Th e eleven chapters of the book introduce the read-
er to a fascinating but somewhat alien world, where the 
supernatural is commonplace, and the timing of the 
harvest of appropriate therapeutic herbs, sympathetic 
magic, ritual proclamations, transference, numerology, 
amulets, charms and talismans, were all used in the 
treatment of the sick. Such therapies as the eyes of liv-
ing ravens, mandrake root, the Nine Herbs Charm, 
stepping over dead men’s graves, and a wide range of 
herbal simples are discussed, as is the prominence of 
women folk-healers.
Intelligently and clearly written, with the support of 
relevant quotes from a range of Anglo-Saxon texts, clas-
sical and historical sources as well as modern academic 
writers, this book brings some interesting new perspec-
tives to a consideration of Anglo-Saxon medical texts. 
A useful – but not comprehensive – bibliography accom-
panies the text, which is also supported by eight pages 
of black and white illustrations; although relevant to the 
book’s content, these are not tied directly to the text.
Th is book is certainly an interesting read, providing 
a stimulating new perspective to a rather neglected area 
of historical medical literature.
Reviewer’s Addresses: Dr Christopher J. Duffi  n, Scien-
tifi c Associate, Department of Earth Science, Palaeon-
tology Section, Th e Natural History Museum, Crom-
well Road, London SW7 5BD, UK, and 146 Church 
Hill Road, Sutton, Surrey, SM3 8NF, UK.
Email: cduffi  n@blueyonder.co.uk.
Reviewed by Christopher J. Duffi  n
To read this book is to enter the arcane world of Anglo-
Saxon medicine, where a drink of ale containing egg 
and sheep’s dung was the cure for a spider’s bite, and 
jumping three times over the grave of a dead man was 
part of the treatment for failure to conceive. 
Anglo-Saxon medical texts are rather few and far 
between. Th e most famous – and the one forming the 
focus of this book – is a manuscript in the British Li-
brary (Royal 12, D xvii), generally referred to as the 
Leechbook of Bald, the earliest translation of which was 
produced by the Rev. Oswald Cockayne in 1864. Si-
néad Spearing, formerly a professional musician and 
now a psychological historian with a special interest in 
Old English medicine, concentrates on the third sec-
tion of Bald’s Leechbook.
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Malarial Subjects: Empire, Medicine and 
Nonhumans in British India, 1820-1909
By Rohan Deb Roy
Cambridge, UK: Cambridge University Press, 2017. 
Pp. xvi + 332. Hardback, price £78.99. ISBN 
9781107172364. An online version of this work is pub-
lished at http://dx.doi.org/10.1017/9781316771617 un-
der a Creative Commons Open Access licence.
the contested production of knowledge about malaria, 
mosquitoes and quinine in British India in the long 
nineteenth century. Drawing mainly on papers in the 
National Archives of India, this is an account that gives 
a welcome emphasis to the story in India, and to the 
actions of native villagers and physicians, alongside 
those of European settlers and quinologists. Th rough-
out, the book challenges simplistic tellings of the qui-
nine story or the workings of empire. 
Moving through a series of episodes – the framing 
of malaria as a colonial disease, the malaria outbreaks 
of the Burdwan region of Bengal, the development of 
cinchona plantations, and the transformation of under-
standing of malaria in the 1890s – quinine is always at 
the centre. Deb Roy begins with a delicate and nuanced 
account of the introduction of cinchona trees to India, 
highlighting the initial perceptions of the cinchona tree 
as a fragile and exotic plant, the many disagreements 
over its means of cultivation, and its transition to what 
proved to be a mundane and easily cultivated plant. A 
major topic is then the disputed purity of the quinine 
alkaloids extracted from trees in the Indian Plantations, 
in contrast to those extracted in London. Here Deb Roy 
draws attention to the practical diffi  culties of alkaloid 
extraction in India, which was often more expensive 
than quinine on world markets, and to the confl icts of 
interest of pharmaceutical wholesalers such as Howards 
in London. Th ese had a major role in guiding Indian 
production, and yet were both major consumers of In-
dian bark and exporters of quinine to India. Moving 
beyond production and manufacture, the book also in-
vestigates the delivery of quinine to Indian consumers, 
whether through native pharmacists or via post offi  ces.
I fi nd it hard to summarise this book in a short re-
view: it is extraordinarily rich in provocative ideas and 
fresh views, many gained through close reading of nine-
teenth century printed texts and archives. Densely ar-
gued yet readable, the book has a notably rich bibliog-
raphy and many well-chosen images. Many aspects of 
its methodology, such as its emphasis on the agency of 
Bengal villagers and physicians, or indeed of non-hu-
mans such as malaria and cinchona, will be infl uential 
in any future study of the subject. Th e book touches on 
many more aspects of malaria and quinine than those 
discussed above, and is thus essential reading for all in-
terested in malaria and quinine, at any period in the 
history of this disease and its entangled treatment. 
Reviewer’s address: Mark Nesbitt, curator of the Eco-
nomic Botany Collection, Royal Botanic Gardens, 
Kew, London TW9 3AE, UK. Email: Mark Nesbitt: 
M.Nesbitt@kew.org.
Reviewed by Mark Nesbitt
Th e history of quinine, and the bark of the cinchona 
tree from which it is derived, is one of the big subjects 
of the history of pharmacy. Th e outline of the story is 
well-known: the discovery 400 years ago that cinchona 
bark was one of the few eff ective treatments for malar-
ia; its export on a massive scale from the Andes to Eu-
rope; the isolation of quinine alkaloids in 1820 by Pel-
letier and Caventou, and the appropriation of the tree 
and its transfer to Asian plantations by the British and 
Dutch empires in the mid-nineteenth century. Yet qui-
nine’s history is often shrouded in legend, and the de-
tails of the processes and motivations involved in its 
acquisition and use remain unclear. 
Processes and motivations are at the heart of Rohan 
Deb Roy’s bold book, which takes as a central theme 
https://doi.org/10.24355/dbbs.084-202007300934-0
